---
title: "On the Compositional Generalization of Multimodal LLMs for Medical Imaging"
summary: "ì˜ë£Œ ì˜ìƒì— ëŒ€í•œ ë‹¤ì¤‘ ëª¨ë“œ ê±°ëŒ€ ì–¸ì–´ ëª¨ë¸ì˜ ì¼ë°˜í™” ëŠ¥ë ¥ í–¥ìƒì— êµ¬ì„±ì  ì¼ë°˜í™”(CG)ê°€ í•µì‹¬ ì—­í• ì„ ìˆ˜í–‰í•˜ë©°, ì œí•œëœ ë°ì´í„°ì—ì„œë„ íš¨ê³¼ì ì„ì„ ë°í˜."
categories: ["AI Generated", "ğŸ¤— Daily Papers"]
tags: ["Computer Vision", "Visual Question Answering", "ğŸ¢ Chinese University of Hong Kong, Shenzhen",]
showSummary: true
date: 2024-12-28
draft: false
---

<br>

{{< keywordList >}}
{{< keyword icon="fingerprint" >}} 2412.20070 {{< /keyword >}}
{{< keyword icon="writer" >}} Zhenyang Cai et el. {{< /keyword >}}
 
{{< keyword >}} ğŸ¤— 2024-12-31 {{< /keyword >}}
 
{{< /keywordList >}}

{{< button href="https://arxiv.org/abs/2412.20070" target="_self" >}}
â†— arXiv
{{< /button >}}
{{< button href="https://huggingface.co/papers/2412.20070" target="_self" >}}
â†— Hugging Face
{{< /button >}}
{{< button href="https://paperswithcode.com/paper/on-the-compositional-generalization-of" target="_self" >}}
â†— Papers with Code
{{< /button >}}




### TL;DR


{{< lead >}}

ì˜ë£Œ ë¶„ì•¼ì—ì„œ ë‹¤ì¤‘ ëª¨ë‹¬ ê±°ëŒ€ ì–¸ì–´ ëª¨ë¸(MLLM)ì˜ í™œìš©ì´ ì¦ê°€í•˜ê³  ìˆì§€ë§Œ, íŠ¹ì • ì˜ë£Œ ì˜ì—­ì˜ ë°ì´í„° ë¶€ì¡±ìœ¼ë¡œ ì¸í•´ ì¼ë°˜í™” ì„±ëŠ¥ì´ ì œí•œì ì…ë‹ˆë‹¤. ê¸°ì¡´ ì—°êµ¬ëŠ” ë‹¤ì¤‘ ê³¼ì œ í•™ìŠµì´ ë‹¨ì¼ ê³¼ì œ í•™ìŠµë³´ë‹¤ ìš°ìˆ˜í•˜ì§€ë§Œ, ê³¼ì œ ê°„ì˜ ë‚´ë¶€ ê´€ê³„ë¥¼ ê³ ë ¤í•˜ì§€ ì•Šì•„ ë°ì´í„°ì…‹ ì„ íƒì— ëŒ€í•œ ëª…í™•í•œ ì§€ì¹¨ì„ ì œê³µí•˜ì§€ ëª»í–ˆìŠµë‹ˆë‹¤. ë³¸ ì—°êµ¬ëŠ” ì´ëŸ¬í•œ ë¬¸ì œë¥¼ í•´ê²°í•˜ê¸° ìœ„í•´ **êµ¬ì„±ì  ì¼ë°˜í™”(CG)**ë¼ëŠ” ê°œë…ì„ ë„ì…í–ˆìŠµë‹ˆë‹¤. CGëŠ” ëª¨ë¸ì´ í•™ìŠµëœ ìš”ì†Œë¥¼ ì¬ê²°í•©í•˜ì—¬ ìƒˆë¡œìš´ ì¡°í•©ì„ ì´í•´í•˜ëŠ” ëŠ¥ë ¥ì„ ì˜ë¯¸í•©ë‹ˆë‹¤.

ë³¸ ì—°êµ¬ì—ì„œëŠ” **ì˜ë£Œ ì˜ìƒì„ Modality, Anatomical area, Task ì„¸ ê°€ì§€ ìš”ì†Œë¡œ ì •ì˜**í•˜ê³ , ì´ë¥¼ ê¸°ë°˜ìœ¼ë¡œ 106ê°œì˜ ì˜ë£Œ ë°ì´í„°ì…‹ì„ í†µí•©í•œ Med-MAT ë°ì´í„°ì…‹ì„ êµ¬ì¶•í–ˆìŠµë‹ˆë‹¤. ì‹¤í—˜ ê²°ê³¼, MLLMì´ CGë¥¼ í†µí•´ ìƒˆë¡œìš´ ì˜ë£Œ ì˜ìƒì„ ì´í•´í•˜ê³ , ë‹¤ì¤‘ ê³¼ì œ í•™ìŠµì—ì„œ ê´€ì°°ë˜ëŠ” ì¼ë°˜í™” í˜„ìƒì˜ ì£¼ìš” ì›ì¸ ì¤‘ í•˜ë‚˜ì„ì„ í™•ì¸í–ˆìŠµë‹ˆë‹¤. ë˜í•œ, CGëŠ” ë°ì´í„°ê°€ ì œí•œì ì¸ ë°ì´í„°ì…‹ì—ì„œë„ íš¨ê³¼ì ì´ë©°, ë‹¤ì–‘í•œ ë°±ë³¸ ëª¨ë¸ì—ì„œ ì¼ê´€ëœ ì„±ëŠ¥ì„ ì œê³µí•¨ì„ ë³´ì˜€ìŠµë‹ˆë‹¤. ì´ ì—°êµ¬ëŠ” **ì˜ë£Œ ì˜ìƒ ë¶„ì„ ë¶„ì•¼ì˜ ì¼ë°˜í™” ë¬¸ì œì— ëŒ€í•œ ìƒˆë¡œìš´ ì ‘ê·¼ ë°©ì‹**ì„ ì œì‹œí•˜ê³ , **ì œí•œëœ ë°ì´í„°ë¥¼ ê°€ì§„ ì˜ë£Œ ì˜ìƒ ë¶„ì„ì— ëŒ€í•œ ìƒˆë¡œìš´ ê°€ëŠ¥ì„±**ì„ ì—´ì—ˆìŠµë‹ˆë‹¤.

{{< /lead >}}


#### Key Takeaways

{{< alert "star" >}}
{{< typeit speed=10 lifeLike=true >}} ì˜ë£Œ ì˜ìƒì„ ì •í™•í•˜ê²Œ ì •ì˜í•˜ëŠ” Modality, Anatomical area, Taskì˜ ì„¸ ê°€ì§€ ìš”ì†Œë¥¼ ê¸°ë°˜ìœ¼ë¡œ êµ¬ì„±ì  ì¼ë°˜í™”(CG) ê°œë…ì„ ì œì‹œ {{< /typeit >}}
{{< /alert >}}

{{< alert "star" >}}
{{< typeit speed=10 startDelay=1000 lifeLike=true >}} ë‹¤ì–‘í•œ ì˜ë£Œ ì˜ìƒ ë°ì´í„°ì…‹ì„ í†µí•©í•œ Med-MAT ë°ì´í„°ì…‹ì„ êµ¬ì¶•í•˜ê³ , ì´ë¥¼ í†µí•´ MLLMì˜ êµ¬ì„±ì  ì¼ë°˜í™” ëŠ¥ë ¥ì„ ì‹¤í—˜ì ìœ¼ë¡œ ê²€ì¦ {{< /typeit >}}
{{< /alert >}}

{{< alert "star" >}}
{{< typeit speed=10 startDelay=2000 lifeLike=true >}} êµ¬ì„±ì  ì¼ë°˜í™”ê°€ ë‹¤ì–‘í•œ ë°±ë³¸ ëª¨ë¸ì—ì„œ ì¼ê´€ë˜ê²Œ ë‚˜íƒ€ë‚˜ë©°, ì œí•œëœ ë°ì´í„°ë¥¼ ê°€ì§„ ë°ì´í„°ì…‹ì—ì„œë„ íš¨ê³¼ì ìœ¼ë¡œ ì¼ë°˜í™” ì„±ëŠ¥ì„ í–¥ìƒì‹œí‚´ {{< /typeit >}}
{{< /alert >}}

#### Why does it matter?
ë³¸ ë…¼ë¬¸ì€ **ì˜ë£Œ ì˜ìƒì— ëŒ€í•œ ë‹¤ì¤‘ ëª¨ë“œ ê±°ëŒ€ ì–¸ì–´ ëª¨ë¸(MLLM)ì˜ ì¼ë°˜í™” ëŠ¥ë ¥ì„ í–¥ìƒì‹œí‚¤ëŠ” ë° ì¤‘ìš”í•œ í†µì°°ë ¥**ì„ ì œê³µí•©ë‹ˆë‹¤.  **êµ¬ì„±ì  ì¼ë°˜í™”(CG)** ê°œë…ì„ ë„ì…í•˜ì—¬ MLLMì´ ìƒˆë¡œìš´ ì˜ë£Œ ì˜ìƒì„ ì´í•´í•˜ëŠ” ë°©ì‹ì„ ë¶„ì„í•˜ê³ , ì œí•œëœ ë°ì´í„°ë¥¼ ê°€ì§„ ë°ì´í„°ì…‹ì—ì„œë„ íš¨ê³¼ì ì„ì„ ë³´ì—¬ì¤ë‹ˆë‹¤. ì´ëŠ” **ì˜ë£Œ ì˜ìƒ ë¶„ì„ ë¶„ì•¼ì˜ ë°œì „ê³¼ ìƒˆë¡œìš´ ì—°êµ¬ ë°©í–¥ ì œì‹œ**ì— í¬ê²Œ ê¸°ì—¬í•˜ë©°, ê´€ë ¨ ì—°êµ¬ìë“¤ì—ê²Œ ì¤‘ìš”í•œ ì˜ë¯¸ë¥¼ ê°€ì§‘ë‹ˆë‹¤.

------
#### Visual Insights



![](https://arxiv.org/html/2412.20070/extracted/6099059/images/Train_and_test_CG2.jpg)

> ğŸ”¼ ê·¸ë¦¼ 1ì€ ëª¨ë¸ì´ í•™ìŠµí•œ ê¸°ë³¸ ìš”ì†Œë“¤ì„ ì¬ê²°í•©í•˜ì—¬ ë³¸ ì  ì—†ëŠ” ìƒˆë¡œìš´ ì´ë¯¸ì§€ë“¤ì„ ì´í•´í•˜ëŠ” ì¡°í•©ì  ì¼ë°˜í™”(Compositional Generalization)ì˜ ê°œë…ì„ ë³´ì—¬ì¤ë‹ˆë‹¤. í›ˆë ¨ ë°ì´í„°ì…‹ì—ëŠ” í°ìƒ‰ ê³ ì–‘ì´, ê²€ì€ ê°œ, MRI ë‡Œ ì´ë¯¸ì§€, CT í ì´ë¯¸ì§€ê°€ í¬í•¨ë˜ì–´ ìˆìŠµë‹ˆë‹¤. í…ŒìŠ¤íŠ¸ ë°ì´í„°ì…‹ì—ëŠ” ê²€ì€ ê³ ì–‘ì´, CT ë‡Œ ì´ë¯¸ì§€ê°€ í¬í•¨ë˜ì–´ ìˆìŠµë‹ˆë‹¤. ëª¨ë¸ì€ í›ˆë ¨ ë°ì´í„°ì…‹ì—ì„œ í•™ìŠµí•œ 'í°ìƒ‰/ê²€ì€ìƒ‰', 'ê³ ì–‘ì´/ê°œ', 'MRI/CT', 'ë‡Œ/í' ì™€ ê°™ì€ ê°œë³„ ìš”ì†Œë“¤ì„ ì¡°í•©í•˜ì—¬ í…ŒìŠ¤íŠ¸ ë°ì´í„°ì…‹ì— ìˆëŠ” ìƒˆë¡œìš´ ì´ë¯¸ì§€ë“¤ì„ ì´í•´í•´ì•¼ í•©ë‹ˆë‹¤.  ì´ëŠ” ë‹¨ìˆœíˆ ê¸°ì¡´ ì´ë¯¸ì§€ë“¤ì„ ì•”ê¸°í•˜ëŠ” ê²ƒë³´ë‹¤ ë” ë†’ì€ ìˆ˜ì¤€ì˜ ì´í•´ì™€ ì¼ë°˜í™” ëŠ¥ë ¥ì„ ìš”êµ¬í•©ë‹ˆë‹¤.
> <details>
> <summary>read the caption</summary>
> Figure 1: Examples of Compositional Generalization: The model is required to understand unseen images by recombining the fundamental elements it has learned.
> </details>





{{< table-caption >}}
| Model | 02 | 03 | 07 | 08 | 09 | 11 | 13 | 14 | 15 | 16 | 18 | 19 | 21 | 22 | 23 | 25 | 26 | 28 | 30 | 31 | 32 | 33 | 35 | 36 | 37 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *Baseline* | 22 | 47 | 40 | 25 | 26 | 27 | 28 | 24 | 22 | 24 | 25 | 23 | 49 | 26 | 25 | 24 | 49 | 30 | 49 | 21 | 49 | 20 | 25 | 23 | 19 |
| *Single-task Training* | 24 | 49 | 50 | 68 | 65 | 76 | 83 | 53 | 61 | 32 | 29 | 26 | 57 | 53 | 28 | 24 | 57 | 64 | 89 | 60 | 97 | 54 | 29 | 51 | 49 |
| *Multi-task Training* | **96** | **89** | **80** | **80** | **79** | **97** | **92** | **88** | **76** | **57** | **88** | **74** | **87** | **86** | **93** | **52** | **98** | **72** | **94** | **61** | **100** | **72** | **75** | **60** | **50** |{{< /table-caption >}}

> ğŸ”¼ í‘œ 1ì€ ë‹¤ì–‘í•œ ëª¨ë¸ì˜ In-Distribution ë°ì´í„°ì…‹ì— ëŒ€í•œ ì •í™•ë„ë¥¼ ë³´ì—¬ì¤ë‹ˆë‹¤. ê° êµ¬ê°„ ë‚´ì—ì„œ ê°€ì¥ ë†’ì€ ì ìˆ˜ëŠ” êµµê²Œ í‘œì‹œí•˜ê³ , ë‘ ë²ˆì§¸ë¡œ ë†’ì€ ì ìˆ˜ëŠ” ë°‘ì¤„ë¡œ í‘œì‹œí•©ë‹ˆë‹¤.  ì´ í‘œëŠ” ë‹¤ì–‘í•œ ëª¨ë¸(ê¸°ì¤€ ëª¨ë¸, ë‹¨ì¼ ì‘ì—… í•™ìŠµ ëª¨ë¸, ë‹¤ì¤‘ ì‘ì—… í•™ìŠµ ëª¨ë¸)ì´ In-Distribution ë°ì´í„°ì…‹ì—ì„œ ì–¼ë§ˆë‚˜ ì •í™•í•˜ê²Œ ë¶„ë¥˜ ì‘ì—…ì„ ìˆ˜í–‰í•˜ëŠ”ì§€ ë¹„êµ ë¶„ì„í•œ ê²°ê³¼ë¥¼ ë³´ì—¬ì¤ë‹ˆë‹¤.  In-Distribution ë°ì´í„°ì…‹ì´ë€ ëª¨ë¸ì´ í•™ìŠµ ê³¼ì •ì—ì„œ ì ‘í–ˆë˜ ë°ì´í„°ì…‹ì„ ì˜ë¯¸í•©ë‹ˆë‹¤.  ë”°ë¼ì„œ ì´ í‘œëŠ” ë‹¤ì¤‘ ì‘ì—… í•™ìŠµì´ ë‹¨ì¼ ì‘ì—… í•™ìŠµë³´ë‹¤ In-Distribution ë°ì´í„°ì…‹ì—ì„œ ë” ë‚˜ì€ ì„±ëŠ¥ì„ ë³´ì´ëŠ”ì§€ í™•ì¸í•˜ëŠ” ë° ë„ì›€ì´ ë©ë‹ˆë‹¤.
> <details>
> <summary>read the caption</summary>
> Table 1: Accuracy of different models on In-Distribution Dataset. Within each segment, bold highlights the best scores, and underlines indicate the second-best.
> </details>





### In-depth insights


#### Med-MAT Dataset
ë³¸ ë…¼ë¬¸ì—ì„œ ì œì‹œëœ Med-MAT ë°ì´í„°ì…‹ì€ **ì˜ë£Œ ì˜ìƒì— ëŒ€í•œ ë‹¤ì–‘í•œ ëª¨ë‹¬ë¦¬í‹°, í•´ë¶€í•™ì  ì˜ì—­, ê·¸ë¦¬ê³  ê³¼ì œë¥¼ í¬ê´„í•˜ëŠ” ë°©ëŒ€í•œ ê·œëª¨ì˜ ë°ì´í„°ì…‹**ì…ë‹ˆë‹¤.  ì´ë¥¼ í†µí•´ ë‹¤ì–‘í•œ ì¡°í•©ì˜ unseen dataì— ëŒ€í•œ ëª¨ë¸ì˜ ì¼ë°˜í™” ëŠ¥ë ¥ì„ í‰ê°€í•˜ê³ , **compositional generalization (CG)**ì˜ íš¨ê³¼ë¥¼ ë¶„ì„í•˜ëŠ” ë° í™œìš©ë©ë‹ˆë‹¤.  **106ê°œì˜ ì˜ë£Œ ë°ì´í„°ì…‹ì„ í†µí•©í•˜ì—¬ êµ¬ì„±**ë˜ì—ˆë‹¤ëŠ” ì ê³¼, ê° ì´ë¯¸ì§€ê°€ **Modality, Anatomical area, Taskì˜ MAT-Tripletìœ¼ë¡œ ì •í™•íˆ ì •ì˜**ë˜ì–´ ìˆë‹¤ëŠ” ì ì€ Med-MATì˜ ì£¼ìš” íŠ¹ì§•ì…ë‹ˆë‹¤.  **MAT-Triplet ê¸°ë°˜ì˜ ë°ì´í„° êµ¬ì„±**ì€ CG ì—°êµ¬ì— ë§¤ìš° ì í•©í•œ í™˜ê²½ì„ ì œê³µí•˜ë©°, ì´ë¥¼ í†µí•´ ë‹¤ì–‘í•œ ì¡°í•©ì˜ unseen ë°ì´í„°ì— ëŒ€í•œ ëª¨ë¸ì˜ ì¼ë°˜í™” ì„±ëŠ¥ì„ íš¨ê³¼ì ìœ¼ë¡œ ë¶„ì„í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.  **ë°ì´í„°ì…‹ì˜ ê³µê°œ**ë¥¼ í†µí•´ ë‹¤ë¥¸ ì—°êµ¬ìë“¤ë„ Med-MATë¥¼ í™œìš©í•˜ì—¬ ì˜ë£Œ ì˜ìƒì— ëŒ€í•œ MLLMì˜ ì¼ë°˜í™” ëŠ¥ë ¥ì— ëŒ€í•œ ì¶”ê°€ ì—°êµ¬ë¥¼ ì§„í–‰í•  ìˆ˜ ìˆê²Œ ë  ê²ƒì…ë‹ˆë‹¤.  ê²°ë¡ ì ìœ¼ë¡œ Med-MATëŠ” ì˜ë£Œ ì˜ìƒ ë¶„ì•¼ì—ì„œ **MLLMì˜ ì¼ë°˜í™” ëŠ¥ë ¥ í–¥ìƒì— í¬ê²Œ ê¸°ì—¬**í•  ë¿ë§Œ ì•„ë‹ˆë¼, **CGì— ëŒ€í•œ ì‹¬ë„ìˆëŠ” ì—°êµ¬ë¥¼ ê°€ëŠ¥í•˜ê²Œ í•˜ëŠ” ì¤‘ìš”í•œ ë°ì´í„°ì…‹**ì…ë‹ˆë‹¤.

#### Compositional Gen
ë³¸ ë…¼ë¬¸ì—ì„œ ì œì‹œëœ "Compositional Gen"(ì¡°í•©ì  ì¼ë°˜í™”) ê°œë…ì€ **ì˜ë£Œ ì˜ìƒì— ëŒ€í•œ ë‹¤ì¤‘ ëª¨ë‹¬ ëŒ€ê·œëª¨ ì–¸ì–´ ëª¨ë¸(MLLM)ì˜ ì¼ë°˜í™” ëŠ¥ë ¥ì„ í–¥ìƒ**ì‹œí‚¤ëŠ” í•µì‹¬ ìš”ì†Œë¡œ ë³´ì…ë‹ˆë‹¤.  **ì˜ë£Œ ì˜ìƒì„ ëª¨ë‹¬ë¦¬í‹°, í•´ë¶€í•™ì  ì˜ì—­, íƒœìŠ¤í¬ì˜ ì„¸ ê°€ì§€ ìš”ì†Œë¡œ ë¶„í•´í•˜ì—¬ ì¡°í•©**í•¨ìœ¼ë¡œì¨, ëª¨ë¸ì´ ì´ì „ì— ë³´ì§€ ëª»í•œ ìƒˆë¡œìš´ ì˜ë£Œ ì˜ìƒ ì¡°í•©ì— ëŒ€í•´ì„œë„ ì´í•´í•  ìˆ˜ ìˆë„ë¡ í•©ë‹ˆë‹¤. ì´ëŠ” ê¸°ì¡´ì˜ ë‹¨ìˆœí•œ ë‹¤ì¤‘ íƒœìŠ¤í¬ í•™ìŠµ ë°©ì‹ë³´ë‹¤ **ë”ìš± íš¨ê³¼ì ì´ê³ , íŠ¹íˆ ë°ì´í„°ê°€ ì œí•œì ì¸ ì˜ë£Œ ì˜ìƒ ë¶„ì•¼ì—ì„œ ìœ ìš©**í•©ë‹ˆë‹¤.  **Med-MAT ë°ì´í„°ì…‹ì€ ì´ëŸ¬í•œ ì¡°í•©ì  ì¼ë°˜í™” ì—°êµ¬ë¥¼ ìœ„í•œ ê°•ë ¥í•œ ê¸°ë°˜**ì„ ì œê³µí•˜ë©°, ë‹¤ì–‘í•œ ë°±ë³¸ ëª¨ë¸ì—ì„œë„ ì¼ê´€ëœ ì„±ëŠ¥ì„ ë³´ì—¬ì¤ë‹ˆë‹¤.  **ê²°ê³¼ì ìœ¼ë¡œ, Compositional Genì€ MLLMì˜ ì¼ë°˜í™” ëŠ¥ë ¥ì„ í–¥ìƒì‹œí‚¤ëŠ” í•µì‹¬ ì›ë™ë ¥**ì„ì„ ì‹œì‚¬í•©ë‹ˆë‹¤.  í•˜ì§€ë§Œ,  ì¼ë¶€ ì œí•œì ì¸ ì‚¬ë¡€ì—ì„œ ì¡°í•©ì  ì¼ë°˜í™”ì˜ íš¨ê³¼ê°€ ëª…í™•í•˜ê²Œ ë“œëŸ¬ë‚˜ì§€ ì•Šì€ ì ì€ ì¶”ê°€ ì—°êµ¬ê°€ í•„ìš”í•¨ì„ ë³´ì—¬ì¤ë‹ˆë‹¤.

#### Multi-task Training
ë³¸ ë…¼ë¬¸ì—ì„œ ë‹¤ë£¨ëŠ” ë‹¤ì¤‘ ì‘ì—… í•™ìŠµ(Multi-task Training)ì€ **ì˜ë£Œ ì˜ìƒ ë¶„ì•¼ì—ì„œ ë‹¤ì–‘í•œ ì‘ì—…ì„ ë™ì‹œì— í•™ìŠµ**ì‹œí‚¤ëŠ” ê¸°ë²•ìœ¼ë¡œ, ê° ì‘ì—…ì´ ì„œë¡œì—ê²Œ ë„ì›€ì„ ì£¼ì–´ **ì¼ë°˜í™” ì„±ëŠ¥ì„ í–¥ìƒ**ì‹œí‚¤ëŠ” ë° ì´ˆì ì„ ë§ì¶”ê³  ìˆìŠµë‹ˆë‹¤.  **ë‹¨ì¼ ì‘ì—… í•™ìŠµë³´ë‹¤ ìš°ìˆ˜í•œ ì„±ëŠ¥**ì„ ë³´ì´ëŠ” ê²ƒìœ¼ë¡œ ë‚˜íƒ€ë‚˜ ìˆìœ¼ë‚˜,  ë³¸ ì—°êµ¬ì—ì„œëŠ” ë‹¨ìˆœíˆ ë‹¤ì–‘í•œ ì‘ì—…ì˜ ì¡°í•©ì´ ì•„ë‹Œ ì‘ì—…ë“¤ ê°„ì˜ ë‚´ì  ê´€ê³„, íŠ¹íˆ **êµ¬ì„±ì  ì¼ë°˜í™”(Compositional Generalization)** ê°œë…ì„ ë„ì…í•˜ì—¬  **ì˜ë£Œ ì˜ìƒ ë°ì´í„° ì„ íƒì— ëŒ€í•œ ìƒˆë¡œìš´ ì§€ì¹¨**ì„ ì œì‹œí•˜ê³  ìˆìŠµë‹ˆë‹¤.  ì´ëŠ” ë‹¤ì–‘í•œ ì˜ë£Œ ì˜ìƒ ë°ì´í„°ì…‹ì„ íš¨ìœ¨ì ìœ¼ë¡œ í™œìš©í•˜ì—¬ íŠ¹ì • ì‘ì—…ì˜ ì„±ëŠ¥ì„ ê°œì„ í•˜ê³ , ì œí•œëœ ë°ì´í„°ë¥¼ ê°€ì§„ ì˜ì—­ì—ì„œë„ **ì¼ë°˜í™” ëŠ¥ë ¥ì„ ë†’ì´ëŠ” ë° ê¸°ì—¬**í•  ìˆ˜ ìˆìŒì„ ì‹œì‚¬í•©ë‹ˆë‹¤.  **Med-MAT ë°ì´í„°ì…‹**ì€ ì´ëŸ¬í•œ ì—°êµ¬ë¥¼ ë’·ë°›ì¹¨í•˜ëŠ” ì¤‘ìš”í•œ ì‹¤í—˜ ê¸°ë°˜ì„ ì œê³µí•˜ê³  ìˆìœ¼ë©°, í–¥í›„ **ì˜ë£Œ ì˜ìƒ ì¸ê³µì§€ëŠ¥ ëª¨ë¸ ê°œë°œ**ì— ì¤‘ìš”í•œ ì‹œì‚¬ì ì„ ì œê³µí•  ê²ƒìœ¼ë¡œ ê¸°ëŒ€ë©ë‹ˆë‹¤.

#### Data Efficiency
ë³¸ ë…¼ë¬¸ì€ ì˜ë£Œ ì˜ìƒì— ëŒ€í•œ ë‹¤ì¤‘ ëª¨ë“œ ê±°ëŒ€ ì–¸ì–´ ëª¨ë¸(MLLM)ì˜ **ì¼ë°˜í™” ëŠ¥ë ¥**ì„ í–¥ìƒì‹œí‚¤ëŠ” ë° ì´ˆì ì„ ë§ì¶”ê³  ìˆìŠµë‹ˆë‹¤. íŠ¹íˆ, ì œí•œëœ ë°ì´í„°ë¡œë„ íš¨ê³¼ì ì¸ í•™ìŠµì´ ê°€ëŠ¥í•˜ë„ë¡ í•˜ëŠ” **ë°ì´í„° íš¨ìœ¨ì„±** ë¬¸ì œì— ëŒ€í•œ ì‹¬ë„ìˆëŠ” ë¶„ì„ì„ ì œê³µí•©ë‹ˆë‹¤.  **í•©ì„± ì¼ë°˜í™”(CG)** ê°œë…ì„ ë„ì…í•˜ì—¬, ëª¨ë¸ì´ í•™ìŠµëœ ìš”ì†Œë“¤ì„ ì¬ê²°í•©í•˜ì—¬ ìƒˆë¡œìš´ ì¡°í•©ì„ ì´í•´í•˜ëŠ” ëŠ¥ë ¥ì„ ê°•ì¡°í•©ë‹ˆë‹¤.  ì‹¤í—˜ ê²°ê³¼ëŠ” **CGê°€ ì œí•œëœ ë°ì´í„°ì…‹ì—ì„œë„ ìš°ìˆ˜í•œ ì„±ëŠ¥ì„ ë³´ì´ë©°, ë‹¤ì–‘í•œ ë°±ë³¸ ëª¨ë¸ì—ì„œ ì¼ê´€ëœ ì„±ëŠ¥ì„ ìœ ì§€**í•¨ì„ ë³´ì—¬ì¤ë‹ˆë‹¤.  ì´ëŠ” **ë°ì´í„° íš¨ìœ¨ì„±ì„ ê·¹ëŒ€í™”**í•˜ê³ , ì˜ë£Œ ì˜ìƒ ì´í•´ë¥¼ ìœ„í•œ MLLMì˜ ì¼ë°˜í™” ëŠ¥ë ¥ì„ ë†’ì´ëŠ” ë° ì¤‘ìš”í•œ ì „ëµì„ì„ ì‹œì‚¬í•©ë‹ˆë‹¤.  **Med-MAT ë°ì´í„°ì…‹**ì˜ í™œìš©ì€ ì´ëŸ¬í•œ ì£¼ì¥ì„ ë’·ë°›ì¹¨í•˜ëŠ” ì‹¤ì¦ì  ì¦ê±°ë¥¼ ì œê³µí•©ë‹ˆë‹¤.  ê²°ë¡ ì ìœ¼ë¡œ, ë³¸ ì—°êµ¬ëŠ” ì˜ë£Œ ì˜ìƒ ë¶„ì„ì—ì„œ MLLMì˜ ë°ì´í„° íš¨ìœ¨ì„±ì„ í¬ê²Œ í–¥ìƒì‹œí‚¬ ìˆ˜ ìˆëŠ” **ìƒˆë¡œìš´ ì ‘ê·¼ ë°©ì‹**ì„ ì œì‹œí•˜ë©°, í–¥í›„ ì˜ë£Œ AI ì—°êµ¬ì— ì¤‘ìš”í•œ ì‹œì‚¬ì ì„ ì œê³µí•©ë‹ˆë‹¤.

#### Future Research
ë³¸ ë…¼ë¬¸ì€ ì˜ë£Œ ì˜ìƒì— ëŒ€í•œ ë‹¤ì¤‘ ì‘ì—… í•™ìŠµì—ì„œ **êµ¬ì„± ì¼ë°˜í™”(Compositional Generalization, CG)**ì˜ ì¤‘ìš”ì„±ì„ ê°•ì¡°í•©ë‹ˆë‹¤.  í•˜ì§€ë§Œ, CGê°€ í•­ìƒ ëª…í™•í•˜ê²Œ ë‚˜íƒ€ë‚˜ëŠ” ê²ƒì€ ì•„ë‹ˆë©°, ë‹¤ë¥¸ ì¼ë°˜í™” ë©”ì»¤ë‹ˆì¦˜ë„ ì¡´ì¬í•  ìˆ˜ ìˆë‹¤ëŠ” ì ì„ ì‹œì‚¬í•©ë‹ˆë‹¤.  **ë¯¸ë˜ ì—°êµ¬ëŠ” ë‹¤ì–‘í•œ ì¼ë°˜í™” ë©”ì»¤ë‹ˆì¦˜ë“¤ì„ íƒêµ¬í•˜ì—¬ ì˜ë£Œ ì˜ìƒì— ëŒ€í•œ MLLMì˜ ì„±ëŠ¥ì„ í–¥ìƒì‹œí‚¤ëŠ” ë°©í–¥ìœ¼ë¡œ ì§„í–‰ë  í•„ìš”ê°€ ìˆìŠµë‹ˆë‹¤.**  íŠ¹íˆ, **ì œí•œëœ ë°ì´í„°ì…‹ì—ì„œì˜ CG í™œìš© ë°©ì•ˆ ì—°êµ¬ëŠ” ì‹¤ì œ ì˜ë£Œ í™˜ê²½ ì ìš©ì— ì¤‘ìš”í•œ ì˜ë¯¸**ë¥¼ ì§€ë‹™ë‹ˆë‹¤.  **ì˜ë£Œ ì˜ìƒì˜ ë‹¤ì–‘í•œ íŠ¹ì§•ë“¤ì„ ë”ìš± ì„¸ë¶„í™”í•˜ì—¬ CGì˜ íš¨ê³¼ë¥¼ ì‹¬ì¸µì ìœ¼ë¡œ ë¶„ì„**í•˜ëŠ” ì—°êµ¬ë„ í•„ìš”í•©ë‹ˆë‹¤.  ë˜í•œ, ë³¸ ì—°êµ¬ëŠ” ì£¼ë¡œ ì˜ë£Œ ë¶„ì•¼ì— ì§‘ì¤‘ë˜ì–´ ìˆìœ¼ë¯€ë¡œ, ë‹¤ë¥¸ **ë‹¤ì¤‘ ëª¨ë‹¬ë¦¬í‹° ì‘ì—…ì— CGë¥¼ ì ìš©í•˜ì—¬ ì¼ë°˜í™” ì„±ëŠ¥ì„ ë¶„ì„í•˜ëŠ” ì—°êµ¬**ë¥¼ í†µí•´ CGì˜ ë²”ìš©ì„±ì„ í™•ì¸í•  í•„ìš”ê°€ ìˆìŠµë‹ˆë‹¤.  **ë‹¤ì–‘í•œ MLLM ë°±ë³¸ ëª¨ë¸ì— ëŒ€í•œ CGì˜ ì ìš©ì„± ì—°êµ¬**ë„ ì¶”ê°€ì ìœ¼ë¡œ ì§„í–‰ë  ìˆ˜ ìˆìŠµë‹ˆë‹¤.  ë§ˆì§€ë§‰ìœ¼ë¡œ, **ì‹¤ì œ ì„ìƒ í™˜ê²½ ì ìš© ì‹œ ë°œìƒí•  ìˆ˜ ìˆëŠ” ìœ„í—˜ ìš”ì†Œì— ëŒ€í•œ ë©´ë°€í•œ ê²€í† ì™€ ì™„í™” ë°©ì•ˆ ë§ˆë ¨**ì„ ìœ„í•œ ì—°êµ¬ê°€ í•„ìˆ˜ì ì…ë‹ˆë‹¤.


### More visual insights

<details>
<summary>More on figures
</summary>


![](https://arxiv.org/html/2412.20070/extracted/6099059/images/mat6.jpg)

> ğŸ”¼ ê·¸ë¦¼ 2ëŠ” Med-MAT ë°ì´í„°ì…‹ì„ ë§Œë“œëŠ” ê³¼ì •ì„ ë³´ì—¬ì¤ë‹ˆë‹¤. 106ê°œì˜ ë‹¤ì–‘í•œ ì˜ë£Œ ë°ì´í„°ì…‹ì´ ëª¨ì—¬ì„œ 11ê°€ì§€ ëª¨ë‹¬ë¦¬í‹°, 14ê°œì˜ í•´ë¶€í•™ì  ì˜ì—­, 13ê°€ì§€ ì˜ë£Œ ê³¼ì œë¥¼ í¬í•¨í•˜ëŠ” 53ê°œì˜ í•˜ìœ„ ë°ì´í„°ì…‹ì„ ìƒì„±í•©ë‹ˆë‹¤. ê° í•˜ìœ„ ë°ì´í„°ì…‹ì€ MAT-Triplet (Modality, Anatomical Area, Task)ìœ¼ë¡œ ì •ì˜ë˜ë©°, ë™ì¼í•œ MAT-Tripletì„ ê³µìœ í•˜ëŠ” ë°ì´í„°ì…‹ì€ í†µí•©ë©ë‹ˆë‹¤. ì´ ê³¼ì •ì„ í†µí•´ ë‹¤ì–‘í•œ ì˜ë£Œ ì˜ìƒ ë°ì´í„°ì˜ í†µí•© ë° êµ¬ì„±ì„ ë³´ì—¬ì¤ë‹ˆë‹¤.  ê° ë°ì´í„°ì…‹ì€ ì§ˆë¬¸-ì‘ë‹µ ìŒ(QA Pairs)ìœ¼ë¡œ ë³€í™˜ë˜ì–´, MLLM(ë‹¤ì¤‘ ëª¨ë‹¬ ëŒ€í˜• ì–¸ì–´ ëª¨ë¸) í•™ìŠµ ë° í‰ê°€ì— ì‚¬ìš©ë©ë‹ˆë‹¤.
> <details>
> <summary>read the caption</summary>
> Figure 2: The process of integrating a vast amount of labeled medical image data to create Med-MAT.
> </details>



![](https://arxiv.org/html/2412.20070/extracted/6099059/images/qaformat.jpg)

> ğŸ”¼ ì´ ê·¸ë¦¼ì€ Med-MAT ë°ì´í„°ì…‹ì˜ ì§ˆë¬¸-ì‘ë‹µ(QA) í˜•ì‹ ë³€í™˜ ê³¼ì •ì„ ë³´ì—¬ì¤ë‹ˆë‹¤. ë‹¤ì–‘í•œ ì˜ë£Œ ì˜ìƒ ë°ì´í„°ì…‹ì„ VQA í˜•ì‹ìœ¼ë¡œ ë³€í™˜í•˜ëŠ” ë°©ë²•ì„ ë‹¨ê³„ë³„ë¡œ ì„¤ëª…í•©ë‹ˆë‹¤. ë¨¼ì €, ê° ë°ì´í„°ì…‹ì˜ ì´ë¯¸ì§€ì™€ ìº¡ì…˜ì„ ë°”íƒ•ìœ¼ë¡œ ì§ˆë¬¸ê³¼ ë„¤ ê°€ì§€ ì„ íƒì§€ê°€ ìˆëŠ” ê°ê´€ì‹ ë¬¸ì œë¥¼ ë§Œë“­ë‹ˆë‹¤. ê·¸ëŸ° ë‹¤ìŒ, ê° ë°ì´í„°ì…‹ì˜ íŠ¹ì„±ì— ë§ëŠ” ì§€ì¹¨ì„ ì¶”ê°€í•˜ì—¬ ëª¨ë¸ì´ ì§ˆë¬¸ì— ì •í™•í•˜ê²Œ ë‹µí•  ìˆ˜ ìˆë„ë¡ ë•ìŠµë‹ˆë‹¤. ë§ˆì§€ë§‰ìœ¼ë¡œ ImageWikiQA ë°ì´í„°ì…‹ì„ ì¶”ê°€í•˜ì—¬ ëª¨ë¸ì˜ ì¼ë°˜í™” ì„±ëŠ¥ì„ í–¥ìƒì‹œí‚¤ê³  í‰ê°€ í¸í–¥ì„ ì¤„ì…ë‹ˆë‹¤.
> <details>
> <summary>read the caption</summary>
> Figure 3: The QA formatting process of Med-MAT.
> </details>



![](https://arxiv.org/html/2412.20070/x5.png)

> ğŸ”¼ ê·¸ë¦¼ 4ëŠ” ë‹¤ì–‘í•œ ëª¨ë¸ì— ëŒ€í•´ íƒ€ê²Ÿ ë°ì´í„°ì…‹ì—ì„œì˜ ì •í™•ë„ ê²°ê³¼ë¥¼ ë³´ì—¬ì¤ë‹ˆë‹¤.  'ëª¨ë“  ê´€ë ¨/ë¬´ê´€ ë°ì´í„°' ëª¨ë¸ì€ íƒ€ê²Ÿ ë°ì´í„°ì™€ ê´€ë ¨ë˜ê±°ë‚˜ ë¬´ê´€í•œ ëª¨ë“  ë°ì´í„°ì…‹ìœ¼ë¡œ í•™ìŠµë˜ì—ˆìŠµë‹ˆë‹¤. 'ëª¨ë“œ/ì˜ì—­/ì‘ì—… ì œì™¸' ëª¨ë¸ì€ ëª¨ë“  ê´€ë ¨ ë°ì´í„°ì…‹ìœ¼ë¡œ í•™ìŠµë˜ì—ˆì§€ë§Œ, íƒ€ê²Ÿ ë°ì´í„°ì™€ ë™ì¼í•œ ìš”ì†Œë¥¼ ê³µìœ í•˜ëŠ” ë°ì´í„°ì…‹ì€ ì œì™¸í•˜ì—¬ ì˜ë„ì ìœ¼ë¡œ CG(í•©ì„± ì¼ë°˜í™”)ë¥¼ ë°©í•´í–ˆìŠµë‹ˆë‹¤. 'ëª¨ë“  ë°ì´í„°'ëŠ” ì‚¬ìš© ê°€ëŠ¥í•œ ëª¨ë“  í•™ìŠµ ì„¸íŠ¸ë¥¼ ì‚¬ìš©í•©ë‹ˆë‹¤. (ì°¸ê³ : ì¼ë°˜í™”ë¥¼ ê´€ì°°í•˜ê¸° ìœ„í•´ íƒ€ê²Ÿ ë°ì´í„°ëŠ” í•™ìŠµì—ì„œ ì œì™¸ë˜ì—ˆìŠµë‹ˆë‹¤.)  ì¦‰, ì´ ê·¸ë¦¼ì€ ë‹¤ì–‘í•œ í•™ìŠµ ì „ëµ(ê´€ë ¨ ë°ì´í„°ë§Œ, ë¬´ê´€ ë°ì´í„°ë§Œ, ê´€ë ¨ ë°ì´í„° ì¤‘ ì¼ë¶€ ì œì™¸)ì„ ì‚¬ìš©í–ˆì„ ë•Œì˜ ì„±ëŠ¥ì„ ë¹„êµí•˜ì—¬ í•©ì„± ì¼ë°˜í™”ì˜ íš¨ê³¼ë¥¼ ë³´ì—¬ì£¼ëŠ” ì‹¤í—˜ ê²°ê³¼ì…ë‹ˆë‹¤.
> <details>
> <summary>read the caption</summary>
> Figure 4: Accuracy results on the Target dataset for various models. â€™All Related/Unrelatedâ€™ models are trained on all the related or unrelated datasets of the Target Data. â€™w/o Modality/Area/Taskâ€™ are trained on All Related datasets but omit those sharing the same element as the Target Data, to intentionally disrupt CG. â€™All Dataâ€™ uses all available training sets. (Note: The Target Data is excluded from training to observe generalization.)
> </details>



</details>




<details>
<summary>More on tables
</summary>


{{< table-caption >}}
| Model | 01 | 04 | 05 | 06 | 10 | 12 | 17 | 20 | 24 | 27 | 29 | 34 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| _Baseline_ | 32 | 25 | 33 | **33** | 48 | 27 | 33 | 13 | 34 | 37 | 31 | 20 |
| _Multi-task Training_ | **39** | **26** | **70** | 31 | **58** | **38** | **61** | **40** | **35** | **41** | **55** | **50** |{{< /table-caption >}}
> ğŸ”¼ í‘œ 2ëŠ” ëª¨ë¸ì˜ Out-of-Distribution(OOD) ë°ì´í„°ì…‹ì— ëŒ€í•œ ì •í™•ë„ë¥¼ ë³´ì—¬ì¤ë‹ˆë‹¤.  OOD ë°ì´í„°ì…‹ì€ ëª¨ë¸ì´ í›ˆë ¨ ì¤‘ì— ì ‘í•´ë³´ì§€ ëª»í•œ ìƒˆë¡œìš´ ìœ í˜•ì˜ ì˜ë£Œ ì˜ìƒ ë°ì´í„°ë¥¼ ì˜ë¯¸í•©ë‹ˆë‹¤.  í‘œëŠ” ì—¬ëŸ¬ ëª¨ë¸(Baseline, Multi-task Training)ì˜ OOD ë°ì´í„°ì…‹ì— ëŒ€í•œ ì •í™•ë„ë¥¼ ë³´ì—¬ì£¼ë©°, ê° ì—´ì€ íŠ¹ì • OOD ë°ì´í„°ì…‹ì— ëŒ€í•œ ì •í™•ë„ë¥¼ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤. ê°€ì¥ ë†’ì€ ì •í™•ë„ë¥¼ ê°€ì§„ ê°’ì€ êµµê²Œ í‘œì‹œë˜ì–´ ëª¨ë¸ì˜ ì¼ë°˜í™” ì„±ëŠ¥ì„ ë¹„êµí•˜ëŠ” ë° ë„ì›€ì´ ë©ë‹ˆë‹¤. ì´ í‘œëŠ” ë‹¤ì–‘í•œ ëª¨ë¸ì˜ OOD ë°ì´í„°ì— ëŒ€í•œ ì¼ë°˜í™” ëŠ¥ë ¥ì„ í‰ê°€í•˜ëŠ” ë° ì‚¬ìš©ë©ë‹ˆë‹¤.
> <details>
> <summary>read the caption</summary>
> Table 2: Accuracy of different models on Out-Of-Distribution Dataset. Bold highlights the best scores.
> </details>

{{< table-caption >}}
Related Combination | Target Subset | Target Subset | Baseline | Baseline+ | Trained
---|---|---|---|---:|:---: 
Lung, COVID | Brain, **Cancer** | Lung, Cancer | 25 | 25 | 27
Lung, Cancer | Brain, **State** | Lung, State | 47 | 46 | 50
Brain, Cancer | Lung, **State** | Brain, State | 33 | 50 | 57
Bones, Level | Lung, **State** | Bones, State | 49 | 53 | 51
Bones, Level | Brain, **State** | Bones, State | 49 | 53 | 72
Bones, Level | Breast, **Diseases** | Bones, Diseases | 37 | 33 | 39
Bones, Level | Lung, **Diseases** | Bones, Diseases | 37 | 33 | 43
Bones, Level | Chest, **Diseases** | Bones, Diseases | 37 | 31 | 43
Bones, State | Breast, **Diseases** | Bones, Diseases | 37 | 37 | 43
Bones, State | Lung, **Diseases** | Bones, Diseases | 37 | 37 | 43
Lung, COVID | Breast, **Diseases** | Lung, Diseases | 49 | 48 | 51
Lung, COVID | Bones, **Diseases** | Lung, Diseases | 49 | 48 | 52
Lung, COVID | Chest, **Diseases** | Lung, Diseases | 49 | 48 | 51
CT, Cancer | X-ray, **COVID** | CT, COVID | 47 | 46 | 72
CT, COVID | X-ray, **Diseases** | X-ray, COVID | 30 | 21 | 49
CT, State | X-ray, **Diseases** | X-ray, State | 30 | 21 | 46
CT, State | X-ray, **Cancer** | CT, Cancer | 33 | 28 | 28
CT, Brain(State) | X-ray, **Bones** | X-ray, Brain | 49 | 49 | 91
CT, Brain | X-ray, **Lung** | X-ray, Brain | 49 | 50 | 81
CT, Brain(Cancer) | X-ray, **Bones** | X-ray, Brain | 25 | 51 | 74
CT, Brain | X-ray, **Lung** | X-ray, Brain | 49 | 52 | 52
X-ray, Brain | CT, Lung(State) | CT, Brain(State) | 33 | 50 | 60
X-ray, Lung | CT, Brain | CT, Lung(Cancer) | 25 | 25 | 36
X-ray, Lung | CT, Brain(State) | CT, Lung | 47 | 50 | 81
X-ray, Lung | CT, Brain(Cancer) | CT, Lung | 47 | 50 | 71
CT, Lung (State) | X-ray, Bones | X-ray, Lung | 30 | 32 | 28
CT, Lung (State) | X-ray, Brain | X-ray, Lung | 30 | 32 | 35
CT, Lung (Cancer) | X-ray, Bones | X-ray, Lung | 30 | 32 | 41
CT, Lung (Cancer) | X-ray, Brain | X-ray, Lung | 30 | 32 | 42
Der, Skin, Cancer | FP, Fundus, **Diseases** | Der, Skin, Diseases | 25 | 29 | 33
Der, Skin, Cancer | OCT, Retine, **Diseases** | Der, Skin, Diseases | 25 | 29 | 33
Der, Skin, Diseases | DP, Mouth, **Cancer** | Der, Skin, Cancer | 40 | 33 | 63
Der, Skin, Diseases | Mic, Cell, **Cancer** | Der, Skin, Cancer | 40 | 33 | 63
DP, Mouth, State | Der, Skin, **Cancer** | DP, Mouth, Cancer | 48 | 50 | 52
DP, Mouth, State | Mic, Cell, **Cancer** | DP, Mouth, Cancer | 48 | 50 | 55
FP, Fundus, Diseases | Mic, Cell, **Level** | FP, Fundus, Level | 33 | 36 | 42
Mic, Cell, Cell Identification | FP, Fundus, **Level** | Mic, Cell, Level | 23 | 33 | 32
Mic, Cell, Cell identification | Der, Skin, **Cancer** | Mic, Cell, Cancer | 49 | 50 | 50
Mic, Cell, Cell identification | DP, Mouth, **Cancer** | Mic, Cell, Cancer | 49 | 51 | 62
Mic, Cell, Level | Der, Skin, **Cancer** | Mic, Cell, Cancer | 49 | 51 | 52
Mic, Cell, Level | DP, Mouth, **Cancer** | Mic, Cell, Cancer | 49 | 51 | 58
Mic, Cell, Cancer | FP, Fundus, **Level** | Mic, Cell, Level | 23 | 24 | 27{{< /table-caption >}}
> ğŸ”¼ í‘œ 3ì€ ë‹¤ì–‘í•œ ì˜ë£Œ ì˜ìƒ ë¶„ë¥˜ ì‘ì—…ì— ëŒ€í•œ ëª¨ë¸ì˜ ì¼ë°˜í™” ì„±ëŠ¥ì„ ë³´ì—¬ì¤ë‹ˆë‹¤. 'ê´€ë ¨ ì¡°í•©' ì—´ì€ ëª¨ë¸ í•™ìŠµì— ì‚¬ìš©ëœ ë°ì´í„°ì…‹ ì¡°í•©ì„ ë‚˜íƒ€ë‚´ê³ , 'ëª©í‘œ í•˜ìœ„ ì§‘í•©' ì—´ì€ ëª¨ë¸ì˜ ì„±ëŠ¥ì„ í‰ê°€í•˜ê¸° ìœ„í•´ ì‚¬ìš©ëœ ë°ì´í„°ì…‹ì„ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤. 'ê¸°ì¤€', 'ê¸°ì¤€+', 'í•™ìŠµ' ì—´ì€ ê°ê° ëª¨ë¸ì´ í•™ìŠµ ì—†ì´, ë¬´ì‘ìœ„ë¡œ ì„ íƒëœ ë¬´ê´€ë ¨ ë°ì´í„°ë¡œ í•™ìŠµëœ ê²½ìš°, ê·¸ë¦¬ê³  ê´€ë ¨ ë°ì´í„°ë¡œ í•™ìŠµëœ ê²½ìš°ì˜ ì •í™•ë„ë¥¼ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤. í‘œì˜ ë…¹ìƒ‰ ì˜ì—­ì€ ì„±ê³µì ì¸ ì¼ë°˜í™”ë¥¼, ë¹¨ê°„ìƒ‰ ì˜ì—­ì€ ì¼ë°˜í™” ì‹¤íŒ¨ë¥¼ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤. ë„¤ ê°œì˜ ì˜ì—­ìœ¼ë¡œ êµ¬ë¶„ëœ ë¶€ë¶„ì€ ê³ ì •ëœ ëª¨ë‹¬ë¦¬í‹°, ê³ ì •ëœ í•´ë¶€í•™ì  ì˜ì—­, ê³ ì •ëœ ì‘ì—…, ê·¸ë¦¬ê³  ëª¨ë‹¬ë¦¬í‹°-í•´ë¶€í•™ì  ì˜ì—­ ìŒ ì¡°í•©ì˜ ë„¤ ê°€ì§€ ë‹¤ë¥¸ ë°©í–¥ ìœ í˜•ì„ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤.
> <details>
> <summary>read the caption</summary>
> Table 3: Generalization results on classification datasets: 'Related Combination' is the training set, 'Target Subset' is the goal. Baseline, Baseline+, and Trained represent the modelâ€™s accuracy without training, trained on randomly sampled unrelated data, and trained on related data, respectively. Green section indicates successful generalization, while red section denotes failure. The 4 segmented areas represent different Direction Types: fixed modality, fixed area, fixed task, and modality-area paired combinations.
> </details>

{{< table-caption >}}
| Related Combination | Target Subset | Baseline | Trained |
|---|---|---|---| 
| **CT** - Subset02 | **Brain** - Subset22 | **Cancer** - Subset07 | CT, Brain, Cancer | 28 | 26 |
| **CT** - Subset03 | **Brain** - Subset22 | **Cancer** - Subset21 | CT, Brain, Cancer | 28 | 25 |
| **CT** - Subset02 | **Brain** - Subset22 | **State** - Subset09 | CT, Brain, State | 33 | 64 |
| **CT** - Subset03 | **Brain** - Subset22 | **State** - Subset26 | CT, Brain, State | 33 | 70 |
| **X-ray** - Subset25 | **Lung** - Subset03 | **Diseases** - Subset02 | X-ray, Lung, Diseases | 30 | 45 |
| **X-ray** - Subset26 | **Lung** - Subset03 | **Diseases** - Subset02 | X-ray, Lung, Diseases | 30 | 38 |
| **X-ray** - Subset26 | **Lung** - Subset03 | **Diseases** - Subset08 | X-ray, Lung, Diseases | 30 | 44 |
| **X-ray** - Subset26 | **Breast** - Subset24 | **Diseases** - Subset02 | X-ray, Breast, Diseases | 31 | 32 |
| **X-ray** - Subset28 | **Breast** - Subset24 | **Diseases** - Subset08 | X-ray, Breast, Diseases | 31 | 52 |{{< /table-caption >}}
> ğŸ”¼ í‘œ 4ëŠ” MAT-Tripletì˜ ì„¸ ê°€ì§€ ìš”ì†Œë¥¼ ì œê³µí•˜ëŠ” ì„¸ ê°€ì§€ ë°ì´í„°ì…‹ì—ì„œì˜ ì¼ë°˜í™” ê²°ê³¼ë¥¼ ë³´ì—¬ì¤ë‹ˆë‹¤. ì´ í‘œëŠ” ì„¸ ê°€ì§€ ë‹¤ë¥¸ ë°ì´í„°ì…‹ì˜ MAT-Triplet ìš”ì†Œë¥¼ ì‚¬ìš©í•˜ì—¬ ëª¨ë¸ì˜ ì¼ë°˜í™” ì„±ëŠ¥ì„ í‰ê°€í•˜ê¸° ìœ„í•œ ì‹¤í—˜ ê²°ê³¼ë¥¼ ë³´ì—¬ì¤ë‹ˆë‹¤. 'ê´€ë ¨ ì¡°í•©' ì—´ì€ í›ˆë ¨ì— ì‚¬ìš©ëœ ë°ì´í„°ì…‹ì„ ë‚˜íƒ€ë‚´ê³ , 'ëŒ€ìƒ í•˜ìœ„ ì§‘í•©' ì—´ì€ ëª¨ë¸ì˜ ì„±ëŠ¥ì„ í‰ê°€í•œ ë°ì´í„°ì…‹ì„ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤. 'ê¸°ì¤€' ì—´ì€ í›ˆë ¨ ì—†ì´ ëª¨ë¸ì˜ ì •í™•ë„ë¥¼ ë‚˜íƒ€ë‚´ê³ , 'í›ˆë ¨ë¨' ì—´ì€ ê´€ë ¨ ë°ì´í„°ë¡œ í›ˆë ¨ëœ ëª¨ë¸ì˜ ì •í™•ë„ë¥¼ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤. ë…¹ìƒ‰ ì˜ì—­ì€ ì„±ê³µì ì¸ ì¼ë°˜í™”ë¥¼ ë‚˜íƒ€ë‚´ê³ , ë¹¨ê°„ìƒ‰ ì˜ì—­ì€ ì‹¤íŒ¨ë¥¼ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤. ì´ í‘œëŠ” 3ê°€ì§€ ìš”ì†Œ ëª¨ë‘ ë‹¤ë¥¸ ë°ì´í„°ì…‹ì—ì„œ ê°€ì ¸ì˜¨ ê²½ìš°ì—ë„ ëª¨ë¸ì´ ì¼ë°˜í™”í•  ìˆ˜ ìˆìŒì„ ë³´ì—¬ì¤ë‹ˆë‹¤.
> <details>
> <summary>read the caption</summary>
> Table 4: Generalization results from 3 datasets providing different elements of MAT-Triplet (RQ 3). 'Related Combination' is the training set, 'Target Subset' is the goal. Baseline, and Trained represent the modelâ€™s accuracy without training and trained on Related data, respectively. Green section indicates successful generalization, while red section denotes failure.
> </details>

{{< table-caption >}}
| Related Combination | Target Subset | Target Subset | Baseline | Trained |
|---|---|---|---|---|
| Lung, Lung Det | Bones, **Diseases** | Lung, Diseases | 49 | 52 |
| Lung, Lung Det | Breast, **Diseases** | Lung, Diseases | 49 | 54 |
| Bones, Spinal Error Det | Breast, **Diseases** | Bones, Diseases | 20 | 30 |
| Bones, Spinal Error Det | Lung, **Diseases** | Bones, Diseases | 20 | 33 |
| MRI, **Diseases Det** | End, Level | End, Diseases | 24 | 27 |
| X-ray, Lung Det | CT, **COVID** | X-ray, COVID | 23 | 26 |
| Der, Skin, Cancer Det | FP, Fundus, **Diseases** | Der, Skin, Diseases | 24 | 29 |
| Mic, Cell, Cancer Det | CT, Kidney, **Diseases** | Mic, Cell, Diseases | 24 | 26 |{{< /table-caption >}}
> ğŸ”¼ í‘œ 5ëŠ” NEXT-Chat ëª¨ë¸ì„ ì‚¬ìš©í•˜ì—¬ ê²€ì¶œ ë° ë¶„ë¥˜ ì‘ì—…ì„ ê²°í•©í•˜ì—¬ ë¶„ë¥˜ ëŒ€ìƒ ë°ì´í„°ì…‹ì„ ì¼ë°˜í™”í•˜ëŠ” ì‹¤í—˜ ê²°ê³¼ë¥¼ ë³´ì—¬ì¤ë‹ˆë‹¤.  'ê´€ë ¨ ì¡°í•©' ì—´ì€ í›ˆë ¨ì— ì‚¬ìš©ëœ ë°ì´í„°ì…‹ì„ ë‚˜íƒ€ë‚´ê³ , 'ëŒ€ìƒ í•˜ìœ„ ë°ì´í„°ì…‹' ì—´ì€ ì¼ë°˜í™” ì„±ëŠ¥ì„ í‰ê°€í•˜ê¸° ìœ„í•œ ëª©í‘œ ë°ì´í„°ì…‹ì„ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤.  'ê¸°ì¤€' ì—´ì€ í›ˆë ¨ ì—†ì´ ëª¨ë¸ì˜ ì •í™•ë„ë¥¼, 'í›ˆë ¨ë¨' ì—´ì€ ê´€ë ¨ ë°ì´í„°ë¡œ í›ˆë ¨ëœ ëª¨ë¸ì˜ ì •í™•ë„ë¥¼ ë³´ì—¬ì¤ë‹ˆë‹¤.  ë…¹ìƒ‰ ì˜ì—­ì€ ì„±ê³µì ì¸ ì¼ë°˜í™”ë¥¼, ë¹¨ê°„ìƒ‰ ì˜ì—­ì€ ì‹¤íŒ¨ë¥¼ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤. í‘œëŠ” ê³ ì • ëª¨ë‹¬ë¦¬í‹°, ê³ ì • ì˜ì—­, ëª¨ë‹¬ë¦¬í‹°-ì˜ì—­ ìŒ ì¡°í•© ë“± ë„¤ ê°€ì§€ ë°©í–¥ ìœ í˜•ìœ¼ë¡œ êµ¬ë¶„ëœ ê²°ê³¼ë¥¼ ë³´ì—¬ì¤ë‹ˆë‹¤. ì´ë¥¼ í†µí•´ ë‹¤ì–‘í•œ ì¡°í•© ë°©ì‹ì— ë”°ë¥¸ ëª¨ë¸ì˜ ì¼ë°˜í™” ì„±ëŠ¥ì„ ë¶„ì„í•©ë‹ˆë‹¤.
> <details>
> <summary>read the caption</summary>
> Table 5: Result of NEXT-Chat on CG by using detection and classification tasks to generalize classification Target dataset. Generalization results on classification datasets: 'Related Combination' is the training set, 'Target Subset' is the goal. Baseline and Trained represent the modelâ€™s accuracy without training and trained on related data, respectively. Green section indicates successful generalization, while red section denotes failure. The 4 segmented areas represent different Direction Types: fixed modality, fixed area, and modality-area paired combinations.
> </details>

{{< table-caption >}}
| Related Combination | Target Subset | Baseline | Trained |
|---|---|---|---| 
| Lung, Lung Det | Bones, **Diseases** | Lung, Diseases | 41 | 47 |
| Lung, Lung Det | Breast, **Diseases** | Lung, Diseases | 41 | 49 |
| Bones, Spinal Error Det | Breast, **Diseases** | Bones, Diseases | 31 | 35 |
| Bones, Spinal Error Det | Lung, **Diseases** | Bones, Diseases | 31 | 37 |
| MRI, **Diseases Det** | End, Level | End, Diseases | 24 | 26 |
| X-ray, Lung Det | CT, **COVID** | X-ray, COVID | 22 | 23 |
| Der, Skin, Cancer Det | FP, Fundus, **Diseases** | Der, Skin, Diseases | 27 | 30 |
| Mic, Cell, Cancer Det | CT, Kidney, **Diseases** | Mic, Cell, Diseases | 20 | 24 |{{< /table-caption >}}
> ğŸ”¼ í‘œ 6ì€ MiniGPT-v2 ëª¨ë¸ì„ ì‚¬ìš©í•˜ì—¬ ê²€ì¶œ ë° ë¶„ë¥˜ ì‘ì—…ì„ í†µí•´ ë¶„ë¥˜ ëŒ€ìƒ ë°ì´í„°ì…‹ì„ ì¼ë°˜í™”í•˜ëŠ” ê³¼ì •ì—ì„œì˜ ì¡°í•© ì¼ë°˜í™”(CG) ê²°ê³¼ë¥¼ ë³´ì—¬ì¤ë‹ˆë‹¤.  'ê´€ë ¨ ì¡°í•©' ì—´ì€ í›ˆë ¨ì— ì‚¬ìš©ëœ ë°ì´í„°ì…‹ì„, 'ëŒ€ìƒ í•˜ìœ„ ë°ì´í„°ì…‹' ì—´ì€ ì¼ë°˜í™” ëª©í‘œ ë°ì´í„°ì…‹ì„ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤.  'ê¸°ì¤€' ì—´ì€ í›ˆë ¨ ì—†ì´ ëª¨ë¸ì˜ ì •í™•ë„ë¥¼, 'í›ˆë ¨ë¨' ì—´ì€ ê´€ë ¨ ë°ì´í„°ë¡œ í›ˆë ¨ëœ ëª¨ë¸ì˜ ì •í™•ë„ë¥¼ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤. ë…¹ìƒ‰ ì˜ì—­ì€ ì„±ê³µì ì¸ ì¼ë°˜í™”ë¥¼, ë¹¨ê°„ìƒ‰ ì˜ì—­ì€ ì‹¤íŒ¨ë¥¼ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤. ì„¸ ê°œì˜ êµ¬ë¶„ëœ ì˜ì—­ì€ ì„¸ ê°€ì§€ ë°©í–¥ ìœ í˜•(ê³ ì • ëª¨ë“œ, ê³ ì • ì˜ì—­, ëª¨ë“œ-ì˜ì—­ ìŒ ì¡°í•©)ì„ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤. ì´ í‘œëŠ” ë‹¤ì–‘í•œ ë°ì´í„° ì¡°í•©ì´ MiniGPT-v2 ëª¨ë¸ì˜ ì¼ë°˜í™” ì„±ëŠ¥ì— ë¯¸ì¹˜ëŠ” ì˜í–¥ì„ ë¶„ì„í•˜ê³ , ì–´ë–¤ ì¡°í•©ì´ íš¨ê³¼ì ì´ê³  ì–´ë–¤ ì¡°í•©ì´ íš¨ê³¼ì ì´ì§€ ì•Šì€ì§€ ë³´ì—¬ì¤ë‹ˆë‹¤.
> <details>
> <summary>read the caption</summary>
> Table 6: Result of MiniGPT-v2 on CG by using detection and classification tasks to generalize classification Target dataset. Generalization results on classification datasets: 'Related Combination' is the training set, 'Target Subset' is the goal. Baseline and Trained represent the modelâ€™s accuracy without training and trained on related data, respectively. Green section indicates successful generalization, while red section denotes failure. The 3 segmented areas represent different Direction Types: fixed modality, fixed area, and modality-area paired combinations.
> </details>

{{< table-caption >}}
| Related Combination | Target Subset | Baseline | Trained |
|---|---|---|---| 
| **Bones**, State, Breast, **Diseases** | **Bones**, Diseases | 61 | 65 |
| **Lung**, COVID, Bones, **Diseases** | **Lung**, Diseases | 80 | 91 |
| CT, **COVID**, X-ray, **Diseases** | **X-ray**, COVID | 35 | 40 |
| CT, **State**, X-ray, **Diseases** | **X-ray**, State | 35 | 43 |
| X-ray, **Lung**, CT, Brain(Cancer) | **CT**, Lung | 32 | 33 |
| X-ray, **Lung**, CT, Brain | **CT**, Lung(Cancer) | 65 | 72 |
| **FP**, Fundus, Diseases, Mic, Cell, **Level** | **FP**, Fundus, Level | 48 | 45 |
| **Mic**, Cell, Cell Identification, FP, Fundus, **Level** | **Mic**, Cell, Level | 34 | 41 |{{< /table-caption >}}
> ğŸ”¼ í‘œ 7ì€ Med-MAT ë°ì´í„°ì…‹ì˜ ì¼ë¶€ ë¶„ë¥˜ ë°ì´í„°ì…‹ì—ì„œ Qwen2-VL ëª¨ë¸ì˜ ì„±ëŠ¥ì„ ë³´ì—¬ì¤ë‹ˆë‹¤.  ê° í–‰ì€ íŠ¹ì • í›ˆë ¨ ë°ì´í„° ì¡°í•©(ê´€ë ¨ ë°ì´í„° ì¡°í•©)ê³¼ í…ŒìŠ¤íŠ¸ ë°ì´í„°ì…‹(íƒ€ê²Ÿ ì„œë¸Œì…‹)ì„ ë‚˜íƒ€ë‚´ë©°, ëª¨ë¸ì´ íƒ€ê²Ÿ ë°ì´í„°ì…‹ì— ëŒ€í•´ ì–¼ë§ˆë‚˜ ì˜ ì¼ë°˜í™”í•˜ëŠ”ì§€ í‰ê°€í•©ë‹ˆë‹¤. ë…¹ìƒ‰ ì˜ì—­ì€ ì„±ê³µì ì¸ ì¼ë°˜í™”ë¥¼, ë¹¨ê°„ìƒ‰ ì˜ì—­ì€ ì¼ë°˜í™” ì‹¤íŒ¨ë¥¼ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤. ì´ í‘œëŠ” ë‹¤ì¤‘ ì‘ì—… í•™ìŠµì—ì„œì˜ ì¡°ì„± ì¼ë°˜í™”(CG)ì˜ íš¨ê³¼ë¥¼ ë¶„ì„í•˜ëŠ” ë° ì‚¬ìš©ë©ë‹ˆë‹¤.  ë‹¤ì–‘í•œ ë°©ì‹ìœ¼ë¡œ ê³ ì •ëœ ëª¨ë‹¬ë¦¬í‹°, ê³ ì •ëœ í•´ë¶€í•™ì  ì˜ì—­, ê³ ì •ëœ ì‘ì—…, ê·¸ë¦¬ê³  ëª¨ë‹¬ë¦¬í‹°-í•´ë¶€í•™ì  ì˜ì—­ ìŒ ì¡°í•©ì„ í†µí•´ CGì˜ ì˜í–¥ì„ í‰ê°€í•©ë‹ˆë‹¤.
> <details>
> <summary>read the caption</summary>
> Table 7: Result of Qwen2-VL on selected classification datasets in Med-MAT. Green section indicates successful generalization, while red section denotes failure.
> </details>

{{< table-caption >}}
| Related Combination | Target Subset | Baseline | Trained |
|---|---|---|---| 
| Bones, State | Breast, **Diseases** | Bones, Diseases | 52 | 59 |
| Lung, COVID | Bones, **Diseases** | Lung, Diseases | 64 | 75 |
| CT, **COVID** | X-ray, Diseases | X-ray, COVID | 33 | 38 |
| CT, **State** | X-ray, Diseases | X-ray, State | 33 | 41 |
| X-ray, **Lung** | CT, Brain(Cancer) | CT, Lung | 31 | 29 |
| X-ray, **Lung** | CT, Brain | CT, Lung(Cancer) | 49 | 57 |
| FP, Fundus, Diseases | Mic, Cell, **Level** | FP, Fundus, Level | 55 | 61 |
| Mic, Cell, Cell Identification | FP, Fundus, **Level** | Mic, Cell, Level | 10 | 32 |{{< /table-caption >}}
> ğŸ”¼ í‘œ 8ì€ Med-MAT ë°ì´í„°ì…‹ì˜ ì¼ë¶€ ë¶„ë¥˜ ë°ì´í„°ì…‹ì— ëŒ€í•´ Llama-3.2-Vision ëª¨ë¸ì˜ ì¼ë°˜í™” ì„±ëŠ¥ì„ ë³´ì—¬ì¤ë‹ˆë‹¤.  í‘œëŠ” ê´€ë ¨ ë°ì´í„° ì¡°í•©(í›ˆë ¨ ì„¸íŠ¸)ê³¼ ëŒ€ìƒ ë°ì´í„°ì…‹(í…ŒìŠ¤íŠ¸ ì„¸íŠ¸)ì„ ë³´ì—¬ì£¼ê³ , ê°ê°ì— ëŒ€í•œ ê¸°ì¤€ ì„±ëŠ¥(Baseline, í›ˆë ¨ ì—†ì´), ê´€ë ¨ ë°ì´í„°ë¡œ í›ˆë ¨ëœ ëª¨ë¸ì˜ ì„±ëŠ¥(Trained)ì„ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤.  ë…¹ìƒ‰ ì˜ì—­ì€ ì„±ê³µì ì¸ ì¼ë°˜í™”ë¥¼, ë¹¨ê°„ìƒ‰ ì˜ì—­ì€ ì¼ë°˜í™” ì‹¤íŒ¨ë¥¼ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤.  ì´ë¥¼ í†µí•´ íŠ¹ì • ë°ì´í„° ì¡°í•©ì´ ëª¨ë¸ì˜ ì¼ë°˜í™” ëŠ¥ë ¥ì— ë¯¸ì¹˜ëŠ” ì˜í–¥ì„ ë¶„ì„í•˜ê³ , Llama-3.2-Vision ëª¨ë¸ì˜ ì¼ë°˜í™” ì„±ëŠ¥ì„ í‰ê°€í•©ë‹ˆë‹¤.
> <details>
> <summary>read the caption</summary>
> Table 8: Result of Llama-3.2-Vision on selected classification datasets in Med-MAT. Green section indicates successful generalization, while red section denotes failure.
> </details>

{{< table-caption >}}
| Subset No. | Modality | Anatomical Area | Task | Datasets No. |
|---|---|---|---|---|
| 01 | Co | Cervix | Cervical Picture Quality Evaluation | 1 |
| 02 | CT | Kidney | Kidney Diseases Classification | 2 |
| 03 | CT | Lung | COVID-19 Classification | 3,4,6 |
| 04 | CT | Lung | Lung Cancer Classification | 5 |
| 05 | CT | Brain | Brain Hemorrhage Classification | 7 |
| 06 | CT | Brain | Brain Cancer Classification | 8 |
| 07 | Der | Skin | Melanoma Type Classification | 10 |
| 08 | Der | Skin | Skin Diseases Classification | 9, 11-15, 71, 72, 74 |
| 09 | DP | Mouth | Teeth Condition Classification | 16 |
| 10 | DP | Mouth | Oral Cancer Classification | 17 |
| 11 | End | Intestine | Intestine Cleanliness Level | 18 |
| 12 | End | Bladder | Cancer Degree Classification | 19 |
| 13 | End | Intestine | Intestine Diseases Classification | 20 |
| 14 | FP | Fundus | Eye Diseases Classification | 21-23, 26-28, 31, 32, 75 |
| 15 | FP | Fundus | Multiple-labels Eye Diseases Classification | 24, 25, 68 |
| 16 | FP | Fundus | Blindness Level | 29 |
| 17 | FP | Fundus | Retinal Images Quality Evaluation | 30 |
| 18 | Mic | Cell | Cell Type Classification | 33, 36-38, 39-41, 44, 65, 70 |
| 19 | Mic | Cell | Prostate Cancer Degree Classification | 34 |
| 20 | Mic | Cell | Multiple-labels Blood Cell Classification | 35 |
| 21 | Mic | Cell | Cancer Classification | 42, 67 |
| 22 | MRI | Brain | Head Diseases Classification | 44, 45 |
| 23 | OCT | Retina | Retina Diseases Classification | 46, 47 |
| 24 | US | Breast | Breast Cancer Classification | 48 |
| 25 | X-ray | Bones | Degree Classification of Knee | 49, 53 |
| 26 | X-ray | Bones | Fractured Classification | 50, 51 |
| 27 | X-ray | Bones | Vertebrae Diseases Classification | 52 |
| 28 | X-ray | Lung | COVID-19 and Pneumonia Classification | 54-57, 60, 62, 81 |
| 29 | X-ray | Breast | Breast Diseases Classification | 58, 78 |
| 30 | X-ray | Lung | Tuberculosis Classification | 59, 79 |
| 31 | X-ray | Chest | Multiple-labels Chest Classification | 61, 73, 76, 77, 80, 85, 87 |
| 32 | X-ray | Brain | Tumor Classification | 63 |
| 33 | Mic | Cell | Multi-labels Diseases | 84 |
| 34 | FP | Fundus | Level Identification | 66 |
| 35 | X-ray | Bones | Level Identification | 69 |
| 36 | X-ray | Bones | Spinal lesion Classification | 86 |
| 37 | X-ray | Breast | Multi-labels Diseases | 82 |
| 38 | Der | Skin | Lesion Det/Seg | 88-91 |
| 39 | End | Intestine | PolyP Det/Seg | 92-93 |
| 40 | End | Intestine | Surgical Procedures Det/Seg | 94 |
| 41 | End | Intestine | Multi-labels Det/Seg | 95 |
| 42 | Mic | Cell | Cancer Cell Det/Seg | 96 |
| 43 | US | Chest | Cancer Det/Seg | 97 |
| 44 | US | Thyroid | Thyroid Nodule Region Det/Seg | 98 |
| 45 | MRI | Intestine | Multi-labels Det/Seg | 103 |
| 46 | MRI | Liver | Liver Det/Seg | 104, 105 |
| 47 | X-ray | Lung | Lung Det/Seg | 99 |
| 48 | X-ray | Lung | Pneumothorax Det/Seg | 106 |
| 49 | X-ray | Bones | Spinal Anomaly Det | 100 |
| 50 | X-ray | Chest | Multi-labels Det | 101, 102 |
| 51 | FP | Fundus | Vessel Seg | 107 |
| 52 | FP | Fundus | Optic Disc and Cup Seg | 108 |{{< /table-caption >}}
> ğŸ”¼ í‘œ 9ëŠ” Med-MAT ë°ì´í„°ì…‹ì˜ í•˜ìœ„ ë°ì´í„°ì…‹ì— ëŒ€í•œ ì„¸ë¶€ ì •ë³´ë¥¼ ë³´ì—¬ì¤ë‹ˆë‹¤.  ê° í•˜ìœ„ ë°ì´í„°ì…‹ì€ ì˜ë£Œ ì˜ìƒì˜ ì¢…ë¥˜(ì˜ˆ: ì»´í“¨í„° ë‹¨ì¸µ ì´¬ì˜(CT), ìê¸° ê³µëª… ì˜ìƒ(MRI), ì´ˆìŒíŒŒ(US) ë“±), í•´ë¶€í•™ì  ì˜ì—­(ì˜ˆ: í, ë‡Œ, í”¼ë¶€ ë“±), ê·¸ë¦¬ê³  ìˆ˜í–‰ëœ ì˜ë£Œ ì‘ì—…(ì˜ˆ: ì§ˆë³‘ ë¶„ë¥˜, ë³‘ë³€ ê²€ì¶œ ë“±)ì„ ê¸°ì¤€ìœ¼ë¡œ ë¶„ë¥˜ë©ë‹ˆë‹¤.  í‘œì˜ íŒŒë€ìƒ‰ ë¶€ë¶„ì€ ë¶„ë¥˜ ì‘ì—…ì— ì‚¬ìš©ëœ í•˜ìœ„ ë°ì´í„°ì…‹ì„, ë…¹ìƒ‰ ë¶€ë¶„ì€ ê²€ì¶œ ì‘ì—…ì— ì‚¬ìš©ëœ í•˜ìœ„ ë°ì´í„°ì…‹ì„ ë‚˜íƒ€ëƒ…ë‹ˆë‹¤.  ì•½ì–´ëŠ” ë‹¤ìŒê³¼ ê°™ìŠµë‹ˆë‹¤: Co(ì½œí¬ìŠ¤ì½”í”¼), CT(ì»´í“¨í„° ë‹¨ì¸µì´¬ì˜), DP(ë””ì§€í„¸ ì‚¬ì§„), FP(ì•ˆì € ì‚¬ì§„), MRI(ìê¸° ê³µëª… ì˜ìƒ), OCT(ê´‘ê°„ì„­ ë‹¨ì¸µì´¬ì˜), Der(í”¼ë¶€ê²½ê²€ê²½), End(ë‚´ì‹œê²½), Mic(í˜„ë¯¸ê²½ ì˜ìƒ), US(ì´ˆìŒíŒŒ).
> <details>
> <summary>read the caption</summary>
> Table 9: The details of subset. In particular, Co stands for Colposcopy, CT represents Computed Tomography, DP refers to Digital Photography, FP is for Fundus Photography, MRI denotes Magnetic Resonance Imaging, OCT signifies Optical Coherence Tomography, Der refers to Dermoscopy, End stands for Endoscopy, Mic indicates Microscopy Images, and US represents Ultrasound. The blue section represents the classification dataset and the green section represents the detection
> </details>

{{< table-caption >}}
| No. | Name | Description | Citation |
|---|---|---|---| 
| 1 | <a href="https://www.kaggle.com/competitions/intel-mobileodt-cervical-cancer-screening/data">Intel &amp; MobileODT Cervical Screening</a> | Cervix Type in Screening | BenO et al. (2017) |
| 2 | <a href="https://www.kaggle.com/datasets/nazmul0087/ct-kidney-dataset-normal-cyst-tumor-and-stone">CT Kindney Dataset</a> | Normal or Cyst or Tumor | Islam et al. (2022a) |
| 3 | <a href="https://www.kaggle.com/datasets/plameneduardo/sarscov2-ctscan-dataset">SARS-COV-2 Ct-Scan</a> | COVID19, Classification Dataset | Soares et al. (2020) |
| 4 | <a href="https://tianchi.aliyun.com/dataset/106604">COVID CT COVID-CT</a> | COVID19, Classification Dataset. | Zhao et al. (2020) |
| 5 | <a href="https://tianchi.aliyun.com/dataset/93929">Chest CT-Scan</a> | Cancer Classification | SunneYi (2021) |
| 6 | <a href="https://tianchi.aliyun.com/dataset/93666">COVID-19-CT SCAN IMAGES</a> | COVID19, Classification | wjXiaochuangw (2019) |
| 7 | <a href="https://www.kaggle.com/datasets/felipekitamura/head-ct-hemorrhage?select=labels.csv">Head CT</a> | Head Hemorrhage | Kitamura (2018) |
| 8 | <a href="https://www.kaggle.com/datasets/trainingdatapro/computed-tomography-ct-of-the-brain">CT of Brain</a> | Head Cancer | Data (2023) |
| 9 | <a href="https://www.cs.rug.nl/%C2%A0imaging/databases/melanoma_naevi/">MED-NODE</a> | Melanoma or Naevus | Giotis et al. (2015) |
| 10 | <a href="https://challenge2020.isic-archive.com/">ISIC 2020</a> | Melanoma, Benign or Malignant | Rotemberg et al. (2021) |
| 11 | <a href="https://data.mendeley.com/datasets/zr7vgbcyr2/1">PED-UFES-20</a> | Skin Multi Classification | Pacheco et al. (2020) |
| 12 | <a href="https://www.kaggle.com/datasets/arafathussain/monkeypox-skin-image-dataset-2022,%20https://www.heywhale.com/mw/dataset/62eb75d6fef0903951b1f199">Web-scraped Skin Image</a> | Skin Desease Multi Classification | Islam et al. (2022b) |
| 13 | <a href="https://www.kaggle.com/datasets/angelachristabel/isbi-2016?select=Training_GroundTruth.csv">ISBI 2016</a> | Skin Lesion Classification | Gutman et al. (2016) |
| 14 | <a href="https://www.kaggle.com/datasets/andrewmvd/isic-2019">ISIC 2019</a> | Skin Desease Multi Classification | Combalia et al. (2019) |
| 15 | <a href="https://www.kaggle.com/datasets/nodoubttome/skin-cancer9-classesisic">Skin Cancer ISIC</a> | Skin Cancer Multi Classification | Katanskiy (2019) |
| 16 | <a href="https://www.kaggle.com/datasets/salmansajid05/oral-diseases/data">Dental Condition Dataset</a> | Teeth condition classification | Sajid (2024) |
| 17 | <a href="https://www.kaggle.com/datasets/zaidpy/oral-cancer-dataset">Oral Cancer Dataset</a> | Oral cancer Classification | RASHID (2024) |
| 18 | <a href="https://datasets.simula.no/nerthus/">The Nerthus Dataset</a> | Cleanliness level | Pogorelov et al. (2017a) |
| 19 | <a href="https://commons.datacite.org/doi.org/10.5281/zenodo.7741475">Endoscopic Bladder Tissue</a> | Canser Degree Classification | Lazo et al. (2023) |
| 20 | <a href="https://www.kaggle.com/datasets/meetnagadia/kvasir-dataset">Kvasir</a> | Multi Disease Classification | Pogorelov et al. (2017b) |
| 21 | <a href="https://figshare.com/s/c2d31f850af14c5b5232">ACRIMA</a> | Glaucoma | Ovreiu et al. (2021) |
| 22 | <a href="https://www.kaggle.com/datasets/nurmukhammed7/augemnted-ocular-diseases">Augemnted ocular diseases AOD</a> | Multi Classification of eye diseases | Ğ‘Ğ°Ò›Ñ‚Ñ‹Ğ±ĞµĞºÒ±Ğ»Ñ‹ (2021) |
| 23 | <a href="https://www.kaggle.com/datasets/linchundan/fundusimage1000">JSIEC</a> | Multi Classification of eye diseases | Cen et al. (2021) |
| 24 | <a href="https://data.mendeley.com/datasets/pc4mb3h8hz/1">Multi-Label Retinal Diseases</a> | Multi Classification of eye diseases | RodrÃ­guez et al. (2022) |
| 25 | <a href="https://github.com/openmedlab/Awesome-Medical-Dataset/blob/main/resources/RFMiD.md">RFMiD 2.0</a> | Multi Classification of eye diseases | Panchal et al. (2023) |
| 26 | <a href="https://www.kaggle.com/datasets/nafin59/ocular-toxoplasmosis-fundus-images-dataset">ToxoFundus(Data Processed Paper)</a> | Ocular toxoplasmosis | Cardozo et al. (2023) |
| 27 | <a href="https://www.kaggle.com/datasets/nafin59/ocular-toxoplasmosis-fundus-images-dataset">ToxoFundus(Data Raw 6class All)</a> | Ocular toxoplasmosis | Cardozo et al. (2023) |
| 28 | <a href="https://www.kaggle.com/datasets/xiaoliang2121/adamdataset">Adam dataset</a> | Age-related Macular Degeneration | Liang (2021) |
| 29 | <a href="https://www.kaggle.com/competitions/aptos2019-blindness-detection">APTOS 2019 Blindness</a> | Blindness Level Identification 0 4 | Karthik et al. (2019) |
| 30 | <a href="https://www.kaggle.com/datasets/subhajournal/drimdb-diabetic-retinopathy-images-database">DRIMBD</a> | Quality Testing of Retinal Images | Prentasic et al. (2013) |
| 31 | <a href="https://www.kaggle.com/datasets/sshikamaru/glaucoma-detection">Glaucoma Detection</a> | Glaucoma Classification | Zhang and Das (2022) |
| 32 | <a href="https://zenodo.org/records/5793241">AIROGS</a> | Glaucoma Classification | de Vente et al. (2023) |
| 33 | <a href="https://github.com/KaikaiZhao/HEp-2_cell_classification">ICPR-HEp-2</a> | Multi Classification | Qi et al. (2016) |
| 34 | <a href="https://data.mendeley.com/datasets/9xxm58dvs3/1">SICAPv2</a> | Cancer Degree Classification | Silva-RodrÃ­guez et al. (2020) |
| 35 | <a href="https://www.kaggle.com/datasets/paultimothymooney/blood-cells">Blood Cell Images</a> | Blood Cell Classificaion (Multi) | Mooney (2017) |
| 36 | <a href="https://www.kaggle.com/datasets/ambarish/breakhis">BreakHis</a> | Cell type and beginormag | Bukun (2019) |
| 37 | <a href="https://bupt-ai-cz.github.io/HSA-NRL/">Chaoyang</a> | Multi Classification of pathologists | Zhu et al.  |
| 38 | <a href="https://data.mendeley.com/datasets/tt3yj2pf38/3">HuSHeM</a> | Sperm Head Morphology Classificaion | Shaker (2018) |
| 39 | <a href="https://www.kaggle.com/datasets/andrewmvd/bone-marrow-cell-classification">Bone Marrow Cell Classification</a> | Bone Marrow Cell Classification | Matek et al. (2021) |
| 40 | <a href="https://zenodo.org/records/1214456">NCT-CRC-HE-100K</a> | Multi Classification | Kather et al. (2018) |
| 41 | <a href="https://www.kaggle.com/datasets/andrewmvd/malignant-lymphoma-classification">Malignant Lymphoma Classification</a> | Multi Classification | Orlov et al. (2010a) |
| 42 | <a href="https://www.kaggle.com/c/histopathologic-cancer-detection/data">Histopathologic Cancer Detection</a> | Cancer Classification | Cukierski (2018) |
| 43 | <a href="https://www.kaggle.com/datasets/xilezhu/lc25000">LC25000</a> | Multi Classification of Lung and Colon | Zhu (2022) |
| 44 | <a href="https://www.kaggle.com/datasets/fernando2rad/brain-tumor-mri-images-17-classes">Brain Tumor 17 Classes</a> | Multi Classification | Feltrin (2022) |
| 45 | <a href="https://www.kaggle.com/datasets/masoudnickparvar/brain-tumor-mri-dataset">Tumor Classification</a> | Pituitary or Glioma or Meningioma or Notumor | Nickparvar (2021a) |
| 46 | <a href="https://www.kaggle.com/datasets/andrewmvd/malignant-lymphoma-classification">Malignant Lymphoma Classification</a> | Multi Classification of eye diseases | Orlov et al. (2010b) |
| 47 | <a href="https://www.kaggle.com/datasets/obulisainaren/retinal-oct-c8">Retinal OCT-C8</a> | Multi Classification of eye diseases | Subramanian et al. (2022) |
| 48 | <a href="https://www.kaggle.com/datasets/sabahesaraki/breast-ultrasound-images-dataset">BUSI</a> | Breast Cancer | Al-Dhabyani et al. (2020) |
| 49 | <a href="https://data.mendeley.com/datasets/t9ndx37v5h/1">Digital Knee X-Ray Images</a> | Degree Classification of Knee | Gornale and Patravali (2020) |
| 50 | <a href="https://www.kaggle.com/datasets/preetviradiya/brian-tumor-dataset">Bone Fracture Multi-Region X-ray Data</a> | Fractured Classification | Nickparvar (2021b) |
| 51 | <a href="https://www.kaggle.com/datasets/devbatrax/fracture-detection-using-x-ray-images">Fracture detection</a> | Fractured Classification | Batra (2024) |
| 52 | <a href="https://www.kaggle.com/datasets/yasserhessein/the-vertebrae-xray-images">The vertebrae X-ray image</a> | Vertebrae | Fraiwan et al. (2022) |
| 53 | <a href="https://www.kaggle.com/datasets/shashwatwork/knee-osteoarthritis-dataset-with-severity">Knee Osteoarthritis Dataset</a> | Knee Osteoarthritis with severity grading | Chen (2018) |
| 54 | <a href="https://lhncbc.nlm.nih.gov/LHC-downloads/downloads.html#tuberculosis-image-data-sets">Shenzhen Chest X-Ray Set</a> | COVID19, Classification Dataset. | Jaeger et al. (2014) |
| 55 | <a href="https://data.mendeley.com/datasets/jctsfj2sfn/1">Chest X-ray PD</a> | COVID and Pneumonia | Asraf and Islam (2021) |
| 56 | <a href="https://www.heywhale.com/mw/dataset/6027caee891f960015c863d7/content">COVID-19 CHEST X-RAY DATABASE</a> | COVID and Pneumonia | Chowdhury et al. (2020) |
| 57 | <a href="https://github.com/ari-dasci/covidgr">COVIDGR</a> | COVID19, Classification | Tabik et al. (2020) |
| 58 | <a href="https://www.kaggle.com/datasets/kmader/mias-mammography">MIAS</a> | Multi Classification of Breast | Mader (2017) |
| 59 | <a href="https://www.kaggle.com/datasets/tawsifurrahman/tuberculosis-tb-chest-xray-dataset">Tuberculosis Chest X-Ray Database</a> | Tuberculosis | Rahman et al. (2020) |
| 60 | <a href="https://www.kaggle.com/datasets/andrewmvd/pediatric-pneumonia-chest-xray">Pediatric Pneumonia Chest X-Ray</a> | Pneumonia Classification | Kermany (2018) |{{< /table-caption >}}
> ğŸ”¼ í‘œ 10ì€ ë…¼ë¬¸ì—ì„œ ì‚¬ìš©ëœ ì˜ë£Œ ë°ì´í„°ì…‹ì— ëŒ€í•œ ì„¸ë¶€ ì •ë³´ë¥¼ ì œê³µí•©ë‹ˆë‹¤.  ê° ë°ì´í„°ì…‹ì˜ ì´ë¦„, ì„¤ëª…, ì¸ìš© ì •ë³´ë¥¼ í¬í•¨í•˜ì—¬ ì´ 109ê°œì˜ ì˜ë£Œ ë°ì´í„°ì…‹ì´ í¬í•¨ë˜ì–´ ìˆìŠµë‹ˆë‹¤. ë°ì´í„°ì…‹ ì„¤ëª…ì—ëŠ” ë°ì´í„°ì…‹ì˜ ìœ í˜•(ì˜ˆ: ë¶„ë¥˜, íƒì§€, ì„¸ë¶„í™”), í•´ë‹¹ë˜ëŠ” ì‹ ì²´ ë¶€ìœ„, ê·¸ë¦¬ê³  ì§ˆë³‘ì˜ ì¢…ë¥˜ ë“±ì´ í¬í•¨ë©ë‹ˆë‹¤. ì´ í‘œëŠ” ë…¼ë¬¸ì—ì„œ ì‚¬ìš©ëœ ë°ì´í„°ì…‹ì— ëŒ€í•œ ì „ë°˜ì ì¸ ê°œìš”ë¥¼ ì œê³µí•˜ì—¬ ì—°êµ¬ì˜ ì¬í˜„ì„±ê³¼ íˆ¬ëª…ì„±ì„ ë†’ì´ëŠ” ë° ê¸°ì—¬í•©ë‹ˆë‹¤.
> <details>
> <summary>read the caption</summary>
> Table 10: The details of the medical datasets are provided
> </details>

{{< table-caption >}}
| No. | Name | Description | Citation |
|---|---|---|---| 
| 61 | <a href="https://www.kaggle.com/datasets/nih-chest-xrays/sample">Random Sample of NIH Chest X-Ray Dataset</a> | Multi Classificaiton of Chest | Wang et al. (2017) |
| 62 | <a href="https://www.kaggle.com/datasets/praveengovi/coronahack-chest-xraydataset">CoronaHack-Chest X-Ray</a> | Pnemonia Classifcition with Virus type | Praveen (2019) |
| 63 | <a href="https://www.kaggle.com/datasets/preetviradiya/brian-tumor-dataset">Brain Tumor Dataset</a> | Tumor Classification | Viradiya (2020) |
| 64 | <a href="https://github.com/mattgroh/fitzpatrick17k">Fitzpatrick 17k (Nine Labels)</a> | Multi Classification | Groh et al. (2021) |
| 65 | <a href="https://figshare.com/s/d6fb591f1beb4f8efa6f">BioMediTech</a> | Multi Classification | Nanni et al. (2016) |
| 66 | <a href="https://zenodo.org/records/4891308">Diabetic retinopathy</a> | Diabetic Retinopathy Level | BenÃ­tez et al. (2021) |
| 67 | <a href="https://tianchi.aliyun.com/dataset/90101/notebook">Leukemia</a> | Cancer Classification | Codella et al. (2019) |
| 68 | <a href="https://odir2019.grand-challenge.org/introduction/">ODIR-5K</a> | Multiple Labels Classification | University (2019) |
| 69 | <a href="https://aistudio.baidu.com/datasetdetail/69582/0">Arthrosis</a> | Bone Age Classification | Zha (2021) |
| 70 | <a href="https://bupt-ai-cz.github.io/HSA-NRL/">HSA-NRL</a> | Multi Classification of pathologists | Zhu et al. (2021) |
| 71 | <a href="https://challenge.isic-archive.com/data/#2018">ISIC 2018 (Task 3)</a> | Multi Classification | Codella et al. (2019) |
| 72 | <a href="https://challenge.isic-archive.com/data/#2018">ISIC 2017 (Task 3)</a> | Multi Classification | Codella et al. (2018) |
| 73 | <a href="https://opendatalab.com/OpenDataLab/ChestX-Det">ChestX-Det</a> | Multi Classification | Lian et al. (2021) |
| 74 | <a href="https://www.kaggle.com/datasets/nafin59/monkeypox-skin-lesion-dataset">Monkeypox Skin Lesion Dataset</a> | Only Monkeypox | Ali et al. (2022) |
| 75 | <a href="https://www.kaggle.com/datasets/jr2ngb/cataractdataset">Cataract Dataset</a> | Multi Classification | JR2NGB (2019) |
| 76 | <a href="https://www.kaggle.com/datasets/raddar/chest-xrays-indiana-university?select=indiana_reports.csv">ChestX-rays IndianaUniversity</a> | Multi-label Classification | Raddar (2019) |
| 77 | <a href="https://www.kaggle.com/datasets/willarevalo/chexpert-v10-small">CheXpert v1.0 small</a> | Multi-label Classification | Arevalo (2020) |
| 78 | <a href="https://www.kaggle.com/datasets/awsaf49/cbis-ddsm-breast-cancer-image-dataset">CBIS-DDSM</a> | Multi Classification | Lee et al. (2017) |
| 79 | <a href="https://www.kaggle.com/datasets/nurkaraca/nlm-montgomerycxrset">NLM-TB</a> | Tuberculosis | Karaca (2022) |
| 80 | <a href="https://nihcc.app.box.com/v/ChestXray-NIHCC/folder/36938765345">ChestXray-NIHCC</a> | Multi-label Classification | Summers and Ronald (2020) |
| 81 | <a href="https://www.kaggle.com/datasets/andyczhao/covidx-cxr2">COVIDx CXR-4</a> | COVID19, Classification | Wang et al. (2020) |
| 82 | <a href="https://www.kaggle.com/datasets/ssmann/vindr-mammo-dataset">VinDr-Mammo</a> | Multi-label Classification | Nguyen et al. (2023) |
| 83 | <a href="https://data.mendeley.com/datasets/snkd93bnjr/1">PBC dataset normal DIB</a> | Multi Classification | Acevedo et al. (2020) |
| 84 | <a href="https://www.kaggle.com/competitions/hpa-single-cell-image-classification/data?select=train.csv">Human Protein Atlas</a> | Multi-label Classification (Only green) | Le et al. (2022) |
| 85 | <a href="https://www.rsna.org/rsnai/ai-image-challenge/rsna-pneumonia-detection-challenge-2018">RSNA Pneumonia Detection Challenge 2018</a> | Multi-label Classification | Anouk Stein et al. (2018) |
| 86 | <a href="https://www.physionet.org/content/vindr-spinexr/1.0.0/">VinDr-SpineXR</a> | Multi Classification of Bones Diseases | Pham et al. (2021) |
| 87 | <a href="https://physionet.org/content/vindr-pcxr/1.0.0/">VinDr-PCXR</a> | Multi-label Classification | Pham et al. (2022) |
| 88 | <a href="https://paperswithcode.com/dataset/ph2">PH2</a> | Melanoma Segmentation | Mendonca et al. (2015) |
| 89 | <a href="https://www.kaggle.com/datasets/angelachristabel/isbi-2016?select=Training_GroundTruth.csv">ISBI 2016 (Task3B)</a> | Melanoma Segmentation | Gutman et al. (2016) |
| 90 | <a href="https://challenge.isic-archive.com/data/#2018">ISIC 2016 (Task 1)</a> | Melanoma Segmentation | Gutman et al. (2016) |
| 91 | <a href="https://challenge.isic-archive.com/data/#2018">ISIC 2017</a> | Melanoma Segmentation | Codella et al. (2018) |
| 92 | <a href="https://polyp.grand-challenge.org/CVCClinicDB/">CVC-ClinicDB</a> | Polyp Segmentation | Bernal et al. (2015) |
| 93 | <a href="https://datasets.simula.no/kvasir-seg/, https://github.com/DebeshJha/2020-MediaEval-Medico-polyp-segmentation/tree/master">Kvasir-SEG</a> | Polyp segmentation | Jha et al. (2020) |
| 94 | <a href="https://www.kaggle.com/datasets/salmanmaq/m2caiseg">m2caiseg</a> | Surgical Instrument Segmentation | Maqbool et al. (2020) |
| 95 | <a href="https://edd2020.grand-challenge.org/Data/">EDD 2020</a> | Multiple Diseases Segmentation in Intestine | Ali et al. (2020) |
| 96 | <a href="https://data.mendeley.com/datasets/9xxm58dvs3/1">SICAPv2</a> | Cancer Cells Segmentation | Silva-RodrÃ­guez et al. (2020) |
| 97 | <a href="https://www.kaggle.com/datasets/sabahesaraki/breast-ultrasound-images-dataset">BUSI</a> | Cancer Segmentation | Hesaraki (2022) |
| 98 | <a href="https://github.com/haifangong/TRFE-Net-for-thyroid-nodule-segmentation">TN3K</a> | Thyroid Nodule Segmentation | Gong et al. (2022) |
| 99 | <a href="https://openi.nlm.nih.gov/imgs/collections/NLM-MontgomeryCXRSet.zip">NLM-TB</a> | Lung Segmentation (With left or right) | Gong et al. (2021) |
| 100 | <a href="https://www.physionet.org/content/vindr-spinexr/1.0.0/">VinDr-SpineXR</a> | Spinal X-ray Anaomaly Detection | Pham et al. (2021) |
| 101 | <a href="https://physionet.org/content/vindr-pcxr/1.0.0/">VinDr-PCXR</a> | Multiple Diseases Segmentation in Chest | Pham et al. (2022) |
| 102 | <a href="https://opendatalab.com/OpenDataLab/ChestX-Det">ChestX-Det</a> | Multiple Diseases Segmentation in Chest | Lian et al. (2021) |
| 103 | <a href="https://www.kaggle.com/competitions/uw-madison-gi-tract-image-segmentation/overview">UW-Madison Gl Tract Image Segmentation</a> | Surgical Instrument Segmentation | Lee et al. (2024) |
| 104 | <a href="https://zenodo.org/records/7774566">Duke Liver Dataset MRI v1</a> | Liver Segmentation | Macdonald et al. (2020) |
| 105 | <a href="https://zenodo.org/records/7774566">Duke Liver Dataset MRI v2</a> | Liver Segmentation | Macdonald et al. (2020) |
| 106 | <a href="https://www.kaggle.com/c/siim-acr-pneumothorax-segmentation">SIIM-ACR Pneumothorax Segmentation</a> | Pneumothorax Segmentation | Zawacki et al. (2019) |
| 107 | <a href="https://figshare.com/articles/figure/FIVES_A_Fundus_Image_Dataset_for_AI-based_Vessel_Segmentation/19688169/1?file=34969398">FIVES</a> | Fundus Vascular Segmentation | Jin et al. (2022) |
| 108 | <a href="https://github.com/miag-ull/rim-one-dl?tab=readme-ov-file">RIM-ONE DL</a> | Optic Disc and Cup Segmentation | Batista et al. (2020) |
| 109 | <a href="https://ieee-dataport.org/documents/palm-pathologic-myopia-challenge">PALM19</a> | Optic Disc Segmentation | Fu et al. (2019) |{{< /table-caption >}}
> ğŸ”¼ í‘œ 10ì˜ ë‚´ìš©ì„ ì‡ëŠ” í‘œì´ë©°, ë‹¤ì–‘í•œ ì˜ë£Œ ë°ì´í„°ì…‹ë“¤ì˜ ì„¸ë¶€ ì •ë³´ë¥¼ ë³´ì—¬ì¤ë‹ˆë‹¤. ê° ë°ì´í„°ì…‹ì˜ ì´ë¦„, ì„¤ëª…, ì¸ìš© ì •ë³´ë¥¼ í¬í•¨í•˜ê³  ìˆìŠµë‹ˆë‹¤. ë°ì´í„°ì…‹ì€ ì§ˆë³‘ ë¶„ë¥˜, ê²€ì¶œ ë° ë¶„í•  ë“± ë‹¤ì–‘í•œ ì˜ë£Œ ì˜ìƒ ë¶„ì„ ì‘ì—…ì— ì‚¬ìš©ë©ë‹ˆë‹¤.  ì˜í•™ì  ëª¨ë‹¬ë¦¬í‹°, í•´ë¶€í•™ì  ì˜ì—­, ì˜í•™ì  ì‘ì—… ë“±ì˜ ì •ë³´ë¥¼ í†µí•´ ë°ì´í„°ì…‹ë“¤ì„ ìƒì„¸íˆ ì„¤ëª…í•©ë‹ˆë‹¤.
> <details>
> <summary>read the caption</summary>
> Table 11: Continued from TableÂ 10.
> </details>

</details>




### Full paper

{{< gallery >}}
<img src="paper_images/1.png" class="grid-w50 md:grid-w33 xl:grid-w25" />
<img src="paper_images/2.png" class="grid-w50 md:grid-w33 xl:grid-w25" />
<img src="paper_images/3.png" class="grid-w50 md:grid-w33 xl:grid-w25" />
<img src="paper_images/4.png" class="grid-w50 md:grid-w33 xl:grid-w25" />
<img src="paper_images/5.png" class="grid-w50 md:grid-w33 xl:grid-w25" />
<img src="paper_images/6.png" class="grid-w50 md:grid-w33 xl:grid-w25" />
<img src="paper_images/7.png" class="grid-w50 md:grid-w33 xl:grid-w25" />
<img src="paper_images/8.png" class="grid-w50 md:grid-w33 xl:grid-w25" />
<img src="paper_images/9.png" class="grid-w50 md:grid-w33 xl:grid-w25" />
<img src="paper_images/10.png" class="grid-w50 md:grid-w33 xl:grid-w25" />
<img src="paper_images/11.png" class="grid-w50 md:grid-w33 xl:grid-w25" />
<img src="paper_images/12.png" class="grid-w50 md:grid-w33 xl:grid-w25" />
<img src="paper_images/13.png" class="grid-w50 md:grid-w33 xl:grid-w25" />
<img src="paper_images/14.png" class="grid-w50 md:grid-w33 xl:grid-w25" />
<img src="paper_images/15.png" class="grid-w50 md:grid-w33 xl:grid-w25" />
<img src="paper_images/16.png" class="grid-w50 md:grid-w33 xl:grid-w25" />
<img src="paper_images/17.png" class="grid-w50 md:grid-w33 xl:grid-w25" />
<img src="paper_images/18.png" class="grid-w50 md:grid-w33 xl:grid-w25" />
<img src="paper_images/19.png" class="grid-w50 md:grid-w33 xl:grid-w25" />
<img src="paper_images/20.png" class="grid-w50 md:grid-w33 xl:grid-w25" />
{{< /gallery >}}